[go: up one dir, main page]

US20210073980A1 - Spatial multiplexing of histological stains - Google Patents

Spatial multiplexing of histological stains Download PDF

Info

Publication number
US20210073980A1
US20210073980A1 US16/950,870 US202016950870A US2021073980A1 US 20210073980 A1 US20210073980 A1 US 20210073980A1 US 202016950870 A US202016950870 A US 202016950870A US 2021073980 A1 US2021073980 A1 US 2021073980A1
Authority
US
United States
Prior art keywords
section
image
sections
sample
primary image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/950,870
Inventor
Matthew Goodman
Todd Huffman
Cody DANIEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3SCAN Inc
Original Assignee
3SCAN Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3SCAN Inc filed Critical 3SCAN Inc
Priority to US16/950,870 priority Critical patent/US20210073980A1/en
Assigned to 3SCAN INC. reassignment 3SCAN INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DANIEL, Cody, GOODMAN, MATTHEW, HUFFMAN, TODD
Publication of US20210073980A1 publication Critical patent/US20210073980A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/04Devices for withdrawing samples in the solid state, e.g. by cutting
    • G01N1/06Devices for withdrawing samples in the solid state, e.g. by cutting providing a thin slice, e.g. microtome
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6456Spatial resolved fluorescence measurements; Imaging
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B21/00Microscopes
    • G02B21/36Microscopes arranged for photographic purposes or projection purposes or digital imaging or video purposes including associated control and data processing arrangements
    • G06K9/00134
    • G06K9/0014
    • G06K9/32
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/30Determination of transform parameters for the alignment of images, i.e. image registration
    • G06T7/33Determination of transform parameters for the alignment of images, i.e. image registration using feature-based methods
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06VIMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00Arrangements for image or video recognition or understanding
    • G06V10/20Image preprocessing
    • G06V10/24Aligning, centring, orientation detection or correction of the image
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06VIMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00Scenes; Scene-specific elements
    • G06V20/60Type of objects
    • G06V20/69Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/693Acquisition
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06VIMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00Scenes; Scene-specific elements
    • G06V20/60Type of objects
    • G06V20/69Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/695Preprocessing, e.g. image segmentation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/286Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
    • G01N2001/2873Cutting or cleaving
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/10Image acquisition modality
    • G06T2207/10056Microscopic image
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30024Cell structures in vitro; Tissue sections in vitro

Definitions

  • the present disclosure generally relates to a method of slicing, imaging, and staining tissue for diagnostic or research purposes.
  • the present disclosure relates to Serial Section Microscopy, the sectioning of biological tissue and other material samples using a microtome, and more specifically, a method of imaging tissue samples stained with immunohistochemical antigens.
  • Immunohistochemistry is a process in which a set of antigens are applied to a section of biological tissue. Immunohistochemical staining is commonly used to identify abnormal cells, employing antibodies to test for certain antigens in a sample of tissue. The antibody is usually linked to a radioactive substance or a dye that causes the antigens in the tissue to become visible under a microscope, and this process is generally done in a panel or series of different stains to detect various cancer cell strains.
  • the present disclosure converges and optimizes of several different workflows that are traditionally used in immunohistochemistry by using the novel methods and processes made possible with the KESM technology.
  • the novel and useful method as described herein can be better understood.
  • the present disclosure generally relates to systems and methods for an imaging an object with a microtome and applying immunohistochemical stains, in order to detect certain biological markers for medical diagnosis or research.
  • the present disclosure relates to using Serial Section Microscopy for these diagnostics, by sectioning biological tissue and other material samples using a Knife Edge Scanning Microscope and applying stains to individual sections, and using a spatial multiplexing method enabled by the Knife Edge Scanning technology to compare various stains and reactions across a sample.
  • the following concerns techniques for rapid pathological and/or histological examination of a tissue sample using multiple contrasting agents By performing an additional imaging step before tissue handling made possible by the Knife Edge Scanning Microscope, the fundamental shape of the imaged object can be captured before physical or chemical deformations are made. Thus, the deformed slice may be registered back into the original coordinate system of the sample. This can also present a unique ability to better co-locate biological markers across many serial sections of a single sample, and can create a more accurate representation of the tissue as a whole by using the intermediate imaging step to re-map individual sections to each other, after chemical or mechanical treatment. This can provide unique advantages by allowing multiple contrast agents to be compared quickly across a sample more quickly than the traditional workflow, with less distortions.
  • FIG. 1A is a schematic illustrating the typical anatomist's workflow using the current state of the art.
  • FIG. 1B is a schematic illustrating the typical histologist or pathologist's workflow using the current state of the art.
  • FIG. 1C is a schematic illustrating the typical biologist's workflow using the current state of the art.
  • FIG. 1 D 1 is a is a schematic illustrating how image distortions occur in traditional workflow using the current state of the art.
  • FIG. 1 D 2 is a schematic illustrating how spatially mulitplexing using the technology described herein improves the process of aligning image stacks by aligning to a non-distorted image.
  • FIG. 2A is a schematic illustrating the steps for imaging a sample using the spatial multiplexing method described herein.
  • FIG. 2B is a schematic illustrating the co-registration of Primary and Secondary Images by side-by-side presentation.
  • FIG. 2C is a schematic illustrating the co-registration of several Z images with different stains applied by mathematical combination to create a composite image of coincident stain reactions.
  • Improved systems and methods are disclosed herein by comparison to the three traditional processes of slicing, staining and imaging tissue samples as described above.
  • the present disclosure includes improvements upon the three aforementioned workflows by introducing an additional imaging step(s) at or before the time of sectioning, enabled by the KESM technology.
  • Immunohistochemistry may refer to the application of antigens or proteins in tissue sections by the use of labeled antibodies as specific reagents that cause antigen-antibody interactions, which can be visualized by a marker such as fluorescent dye or stain.
  • Serial Section Microscopy may refer to the practice of taking serial sections with a microtome and imaging them, traditionally by mounting the slices to glass and staining.
  • KESM Kerne Edge Scanning Microscope
  • “Section” or “slice” may refer to a single strip of contiguous material that was removed from the block face by means of a relative motion between the sample and the knife.
  • Microtomy may refer to a device in which a block of material is precisely cut such that a very thin layer of material is removed, or sectioned, from the surface of the block.
  • microtomy may apply to the operation of microtomes.
  • Imagery may include any technique designed to measure an “image”, a spatial map of an optical or electronic response. This can include optical or electron microscopy techniques.
  • Imaging may generally refer to data collection in order to generate a visualization of a given area.
  • Registration or “co-registration” may refer to a computational step in which images are aligned, stretched, and deformed to match one another. In reference to Serial Sectioning Microscopy, this step can correct for tissue deformation from slicing, mounting, and chemical treatments.
  • Multiplex or “multiplexing” may refer to a method of selecting one location within a matrix by having two selective addressing systems on both sides of the matrix, thus needing only 2N selectors to address NA2 locations.
  • “Stain” may refer to a chemical treatment, which aims to change the photonic response of all or parts of a medium, by methods including but not limited to attaching a pigment, a genetically expressed flourophore, or chemistry designed to modify the target structure to be imaged. This may include but is not limited to traditional light microscopy stains, contrast agents used in immunohistochemistry (IHC) and in situ hybridization (ISH) labeling techniques.
  • IHC immunohistochemistry
  • ISH in situ hybridization
  • Molecular Diagnostic may refer to a form of chemical test or assay, which takes a sample of tissue and identifies biological markers to make a diagnostic.
  • Transformation may refer to the re-mapping of a single point in an image from the unstained image to another stained image.
  • Interpolation may encompass methods for selective spatial sampling of a numerical value derived from another numerical field. Methods commonly used may include “nearest-neighbor” interpolation, linear, polynomial, or b-spline based techniques. These are generally used to compute discreet “interpolant” values of a transformed image, or approximate the value of a function at a given spatial coordinate.
  • the process of capturing and mounting sections from a microtome to a glass slide may physically distort the tissue.
  • the distortion can be a warping of the thin and delicate tissue, a folding of the sections, or even tearing.
  • the warping can prevent simple alignment of serial sections, as the microscopic features may not line up properly from section to section.
  • the distortions must be corrected using a combination of manual editing and software, where registration marks are chosen on the adjacent images and software aligns the registration marks. This process is often slow and difficult, and can prevent the more widespread adoption of serial sectioning.
  • Controlling slice thickness can be important for several reasons:
  • contrast agents which can depend on chemical-kinetics of the base material, may behave differently for thick or thin sections.
  • FIG. 1A is a diagram that illustrates the typical anatomist's workflow 100 A employing the current state of the art.
  • a sample 101 may be sliced into one or more thick sections such as a first thick section 121 A, a second thick section 121 B, and a third thick section 121 B.
  • the thick sections 121 A, 121 B, 121 C may be stained in a step 131 and the stained thick sections 121 A, 121 B, 121 C may then be imaged and co-registered with one another in a step 141 .
  • FIG. 1B is a diagram that illustrates the typical histologist or pathologist's workflow 100 B employing the current state of the art.
  • FIG. 1C is a diagram that illustrates the typical biologist's workflow 100 C employing the current state of the art.
  • the sample 101 can be sliced and placed in a slide in a step 181 .
  • the slice/slide may be stained.
  • the stained slide/slice may be imaged.
  • the image may be stored.
  • the stain may be removed and the slide/slice may be stained once more in a step 191 .
  • Another approach is differential staining of the next section, based on examination from a pathologist. This can lead to fairly long turnaround times, as well as needing increased interaction from the physician.
  • the present disclosure describes systems and methods to decreases the human effort required to process multiple stains on a sample and increase the accuracy of the reconstructed products by introducing an additional imaging step enabled by the KESM technology as applied herein.
  • the slices are aligned using human annotation or algorithms, where the warping during mounting is corrected prior to reconstructions.
  • the process typically involves the selection of registration marks, which are points that occur across adjacent sections.
  • the registration points may be used to calculate a transformation function, which is applied to both images to bring the pixels in the images into alignment.
  • Choosing registration marks across a series of images can be difficult, because each of the images in the stack is different from the next.
  • Features also rarely cross exactly perpendicular to the cutting plane, so if the same features are chosen for registration marks, the features may drift spatially across the sections and thus for example an object at an incline may be misconstrued as being vertical.
  • the post-processing of images may be improved because the post-processing of distortions may be performed on two images of the exact same section, one without distortions and one or more without. Since the images are of the same slice, the same exact registration marks will occur on all images, making the selection process easier and more consistent. The same phenomenon can also reduce spatial drift that would otherwise occur for cylindrical features traveling at an incline relative to the cutting plane.
  • FIG. 1 D 1 and FIG. 1 D 2 illustrate how distortions occur employing the current state of the art (FIG. 1 D 1 ) in comparison to how image post-processing may be improved with regard to these distortions as disclosed herein (FIG. 1 D 2 ).
  • an object 103 may be in present in the sample 101 which may be sliced into two slices 105 A and 105 B. Images 107 A, 107 B may be generated for each slice 105 A, 105 B, respectively, showing the object 103 at different depths.
  • an object 103 may be present in the sample 101 which may be sliced into two slices 105 A and 105 B.
  • Primary and secondary images may be generated for each of the slices 105 A, 105 B (such as primary image 109 A 1 and secondary image 109 A 2 for primary slice 105 A, and primary image 109 B 1 and secondary image 109 B 2 for secondary slice 105 B.)
  • the first step in this method comprises a Primary Imaging (PI) step, which may capture a view of the section before processing or post-processing distortions. This may be accomplished by imaging the sample before slicing or by imaging during slicing.
  • the primary imaging may be performed with a KESM, which may capture an un-warped image on the block face during the slicing operation. These images may be referred to as X_N.
  • the Secondary Imaging (SI) step can have a direct anchor to the actual original shape and location of the slice, which may enable better registration and analysis of stain reactions of a sample.
  • FIG. 2A is a diagram that illustrates the imaging steps for the spatial multiplexing method 200 .
  • the sample 101 may be imaged in a primary imaging step 211 A before a thin section 221 A is sliced from the sample 101 . Further primary imaging steps 211 B to 211 N may be performed before further slicing the sample to further thin sections 221 B to 221 N. The primary images may be collected and registered with one another to generate a virtual thick slice 223 .
  • the slice(s) may be mounted on a glass slide and antigen or protein stains may then be applied in a step 231 to the sample slices for further analysis.
  • SI Secondary Imaging
  • the KESM may be used to image the stained slices of the sample 101 after a stain or a full panel of stains 231 has been applied. These step(s) may be repeated as many times as is desired, re-imaging the slices each time a new stain is applied to the sample. These images will be referred to as Y_n.
  • Another aspect of the disclosure describes a reconstruction step.
  • various computations may be employed to create a reconstructed image across different stained images.
  • the secondary images may be collected and registered with one another to generate a stack of co-registered stains 243 .
  • the primary virtual thick slice 223 and the co-registered stack of stained slices 242 may be analyzed in a data-gathering or diagnosis step 251 .
  • a computational transformation of the Y_n images may be performed to reconstruct and spatially align the various sample slices to each other.
  • the panel of stained Y_n images may be mapped back to the biomarker coordinates established by the X_n images by employing computational transformations. These remapped images will be referred to as Z_n.
  • These computational transformations may include, but are not limited to:
  • Another aspect of the disclosure describes a co-registration step, wherein the images from the PI and SI steps captured by the KESM are compared and aligned to each other based on the mapped biomarkers established in the reconstruction step.
  • the stack of Z_n images may be superimposed to co-register the different stains. This step may be repeated to complete a full panel of stains and compare the results based on the co-registered images.
  • Methods for completing the co-registration step may include:
  • An additional embodiment of a workflow may be similar to the work flow 200 above, with an additional imaging step between the mounting and staining steps.
  • This multiplexing approach gives a larger 3D distribution of the labels across the volume while tethering each slice back to the overall block. Additionally, the stained information could be interpolated across adjacent sections.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Multimedia (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Quality & Reliability (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

The following concerns a method for co-localization of microscopy or histology stains by the assembly of a virtual image from one or more imaging operations. In particular, the method decreases the time required to obtain multiple labeled antigen or protein histology images of a biological sample. The method includes imaging the tissue as it is sliced by a microtome with a knife edge scanning microscope and spatially aligning the samples by the generated images. The spatial alignment of samples enabled by the method allows a panel of different antigen or protein secondary or functional stains to be compared across different sample slices, thereby allowing concurrent secondary stains of tissues and cells.

Description

    CROSS-REFERENCE
  • This application claims benefit as a Continuation of U.S. application Ser. No. 15/205,288, filed Jul. 8, 2016, which claims benefit of U.S. Provisional Application No. 62/190,931, filed Jul. 10, 2015, the entire contents of the aforementioned is hereby incorporated by reference as if fully set forth herein, under 35 U.S.C. § 120. The applicant(s) hereby rescind any disclaimer of claim scope in the parent application(s) or the prosecution history thereof and advise the USPTO that the claims in this application may be broader than any claim in the parent application(s).
  • BACKGROUND
  • The present disclosure generally relates to a method of slicing, imaging, and staining tissue for diagnostic or research purposes. In particular, the present disclosure relates to Serial Section Microscopy, the sectioning of biological tissue and other material samples using a microtome, and more specifically, a method of imaging tissue samples stained with immunohistochemical antigens.
  • Immunohistochemistry is a process in which a set of antigens are applied to a section of biological tissue. Immunohistochemical staining is commonly used to identify abnormal cells, employing antibodies to test for certain antigens in a sample of tissue. The antibody is usually linked to a radioactive substance or a dye that causes the antigens in the tissue to become visible under a microscope, and this process is generally done in a panel or series of different stains to detect various cancer cell strains.
  • The present disclosure converges and optimizes of several different workflows that are traditionally used in immunohistochemistry by using the novel methods and processes made possible with the KESM technology. By presenting the following three studies of traditional workflows that represent the current state of the art, the novel and useful method as described herein can be better understood.
  • SUMMARY
  • The present disclosure generally relates to systems and methods for an imaging an object with a microtome and applying immunohistochemical stains, in order to detect certain biological markers for medical diagnosis or research. In particular, the present disclosure relates to using Serial Section Microscopy for these diagnostics, by sectioning biological tissue and other material samples using a Knife Edge Scanning Microscope and applying stains to individual sections, and using a spatial multiplexing method enabled by the Knife Edge Scanning technology to compare various stains and reactions across a sample.
  • The following concerns techniques for rapid pathological and/or histological examination of a tissue sample using multiple contrasting agents. By performing an additional imaging step before tissue handling made possible by the Knife Edge Scanning Microscope, the fundamental shape of the imaged object can be captured before physical or chemical deformations are made. Thus, the deformed slice may be registered back into the original coordinate system of the sample. This can also present a unique ability to better co-locate biological markers across many serial sections of a single sample, and can create a more accurate representation of the tissue as a whole by using the intermediate imaging step to re-map individual sections to each other, after chemical or mechanical treatment. This can provide unique advantages by allowing multiple contrast agents to be compared quickly across a sample more quickly than the traditional workflow, with less distortions.
  • Other goals and advantages of the disclosure will be further appreciated and understood when considered in conjunction with the following description and accompanying drawings. While the following description may contain specific details describing particular embodiments of the disclosure, they should not be construed as limitations to the scope of the disclosure but rather as an exemplification of preferable embodiments. For each aspect of the disclosure, many variations are possible as suggested herein that are known to those of ordinary skill in the art. A variety of changes and modifications can be made within the scope of the disclosure without departing from the spirit thereof.
  • INCORPORATION BY REFERENCE
  • All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
  • FIG. 1A is a schematic illustrating the typical anatomist's workflow using the current state of the art.
  • FIG. 1B is a schematic illustrating the typical histologist or pathologist's workflow using the current state of the art.
  • FIG. 1C is a schematic illustrating the typical biologist's workflow using the current state of the art.
  • FIG. 1D1 is a is a schematic illustrating how image distortions occur in traditional workflow using the current state of the art.
  • FIG. 1D2 is a schematic illustrating how spatially mulitplexing using the technology described herein improves the process of aligning image stacks by aligning to a non-distorted image.
  • FIG. 2A is a schematic illustrating the steps for imaging a sample using the spatial multiplexing method described herein.
  • FIG. 2B is a schematic illustrating the co-registration of Primary and Secondary Images by side-by-side presentation.
  • FIG. 2C is a schematic illustrating the co-registration of several Z images with different stains applied by mathematical combination to create a composite image of coincident stain reactions.
  • DETAILED DESCRIPTION
  • Improved systems and methods are disclosed herein by comparison to the three traditional processes of slicing, staining and imaging tissue samples as described above. The present disclosure includes improvements upon the three aforementioned workflows by introducing an additional imaging step(s) at or before the time of sectioning, enabled by the KESM technology.
  • Definitions
  • “Immunohistochemistry” may refer to the application of antigens or proteins in tissue sections by the use of labeled antibodies as specific reagents that cause antigen-antibody interactions, which can be visualized by a marker such as fluorescent dye or stain.
  • “Serial Section Microscopy” may refer to the practice of taking serial sections with a microtome and imaging them, traditionally by mounting the slices to glass and staining.
  • “Knife Edge Scanning Microscope” or “KESM” may refer to a microscope that performs Serial Section Microscopy in an automated fashion. See U.S. Pat. No. 6,744,572.
  • “Section” or “slice” may refer to a single strip of contiguous material that was removed from the block face by means of a relative motion between the sample and the knife.
  • “Microtome” may refer to a device in which a block of material is precisely cut such that a very thin layer of material is removed, or sectioned, from the surface of the block. Similarly, the term “microtomy” may apply to the operation of microtomes.
  • “Imagery” may include any technique designed to measure an “image”, a spatial map of an optical or electronic response. This can include optical or electron microscopy techniques.
  • “Imaging” may generally refer to data collection in order to generate a visualization of a given area.
  • “Registration” or “co-registration” may refer to a computational step in which images are aligned, stretched, and deformed to match one another. In reference to Serial Sectioning Microscopy, this step can correct for tissue deformation from slicing, mounting, and chemical treatments.
  • “Multiplex” or “multiplexing” may refer to a method of selecting one location within a matrix by having two selective addressing systems on both sides of the matrix, thus needing only 2N selectors to address NA2 locations.
  • “Stain” may refer to a chemical treatment, which aims to change the photonic response of all or parts of a medium, by methods including but not limited to attaching a pigment, a genetically expressed flourophore, or chemistry designed to modify the target structure to be imaged. This may include but is not limited to traditional light microscopy stains, contrast agents used in immunohistochemistry (IHC) and in situ hybridization (ISH) labeling techniques.
  • “Molecular Diagnostic” may refer to a form of chemical test or assay, which takes a sample of tissue and identifies biological markers to make a diagnostic.
  • “Transformation” may refer to the re-mapping of a single point in an image from the unstained image to another stained image.
  • “Interpolation” may encompass methods for selective spatial sampling of a numerical value derived from another numerical field. Methods commonly used may include “nearest-neighbor” interpolation, linear, polynomial, or b-spline based techniques. These are generally used to compute discreet “interpolant” values of a transformed image, or approximate the value of a function at a given spatial coordinate.
  • Distortions
  • The process of capturing and mounting sections from a microtome to a glass slide may physically distort the tissue. The distortion can be a warping of the thin and delicate tissue, a folding of the sections, or even tearing. The warping can prevent simple alignment of serial sections, as the microscopic features may not line up properly from section to section. Typically, the distortions must be corrected using a combination of manual editing and software, where registration marks are chosen on the adjacent images and software aligns the registration marks. This process is often slow and difficult, and can prevent the more widespread adoption of serial sectioning.
  • Staining and Slice Thickness
  • Controlling slice thickness can be important for several reasons:
      • 1. Maintaining the structural/architectural integrity of the section for subsequent handling, staining, mounting, and processing.
      • 2. Ensuring that the section is an appropriate thickness to the structures being resolved. The slice should be thick enough so that unique features fit within the slice. In cell characterization, the slice is typically a thickness, which allows 1-2 layers of cells in plane. If it is too thick, many layers of cells can obscure the ability to obscure cell level detail. Similarly, if the slice it too thin relevant features within a singular cell layer may be truncated.
      • 3. Ensuring that the slice is thin enough of the chemical kinetics of staining to adequately label the associated features. Many contrast agents employ large molecules, which may be limited in the amount of tissue through which they are able to diffuse and correspondingly label.
  • Similarly contrast agents, which can depend on chemical-kinetics of the base material, may behave differently for thick or thin sections.
  • It is common practice in histology or pathology labs to cut slices of different thickness for different staining/contrasting techniques. This is especially true when rapid results are needed (thin slices typically can be stained more quickly), or complex chemistries are employed in the staining as in IHC or ISH methods.
  • The Anatomist Workflow
  • There are many reasons that a biologist might want to measure a tissue property across a three dimensional volume of space. To do this using the current state of the art, several slices would be cut, stained, and co-registered against one and other. FIG. 1A is a diagram that illustrates the typical anatomist's workflow 100A employing the current state of the art. In a step 111, a sample 101 may be sliced into one or more thick sections such as a first thick section 121A, a second thick section 121B, and a third thick section 121B. The thick sections 121A, 121B, 121C may be stained in a step 131 and the stained thick sections 121A, 121B, 121C may then be imaged and co-registered with one another in a step 141.
  • The Histologist/Pathologist Workflow
  • Similarly, when a histologist or pathologist is attempting to make a diagnosis of diseased tissue, several thick sections 121A, 121B, 121C may be cut. Then, one would be stained, imaged and examined in a step 151. Based on the imagery input from a medical professional, this process could be repeated several times before finally a diagnosis is made in a step 161, and the diagnosis of one of the thick sections may be used to inform the staining, imaging, and examination of further thick sections. The diagnosis of the stained thick sections may indicate an appropriate treatment for the patient in a step 171. FIG. 1B is a diagram that illustrates the typical histologist or pathologist's workflow 100B employing the current state of the art.
  • The Biologist Workflow
  • Biological researchers typically employ an immunohistochemical staining technique where a particular piece of tissue is stained, imaged, then stripped clear of the stain from the section of tissue. The staining and stripping process can be repeated in order to image the immune or antigen reactions of a full panel of stains on the sample piece of tissue. FIG. 1C is a diagram that illustrates the typical biologist's workflow 100C employing the current state of the art. The sample 101 can be sliced and placed in a slide in a step 181. In a step 191, the slice/slide may be stained. In a step 1011, the stained slide/slice may be imaged. In a step 1031, the image may be stored. In a step 1021, the stain may be removed and the slide/slice may be stained once more in a step 191.
  • This process of putting down a stain, imaging, stripping the stain, re-staining, re-imaging the stain, then re-imaging again is known as serial multiplexing. This approach, which is commonly used by biologists in immunohistochemistry, is time consuming, often taking a week or longer to complete a full panel of antigen stains.
  • Another approach is differential staining of the next section, based on examination from a pathologist. This can lead to fairly long turnaround times, as well as needing increased interaction from the physician.
  • All of these approaches have fundamental drawbacks which the scope of this disclosure seeks to address:
      • The slide-mounting, staining, and imaging each introduce unique deformations, distortions, and artifacts in the slices which can make the final process of co-registration difficult, error prone, and time consuming.
      • There are often a large number of serial steps, each of which can involve significant human labor and attention to detail if high-quality reliable results are to be produced.
      • Given the 3D nature of a sample, the features can be changing across even adjacent slices, and automated feature extraction and warp correction has been difficult in larger samples.
  • The present disclosure describes systems and methods to decreases the human effort required to process multiple stains on a sample and increase the accuracy of the reconstructed products by introducing an additional imaging step enabled by the KESM technology as applied herein.
  • Post-Processing Distortions
  • In typical serial section microscopy, the slices are aligned using human annotation or algorithms, where the warping during mounting is corrected prior to reconstructions. The process typically involves the selection of registration marks, which are points that occur across adjacent sections. The registration points may be used to calculate a transformation function, which is applied to both images to bring the pixels in the images into alignment. Choosing registration marks across a series of images can be difficult, because each of the images in the stack is different from the next. Features also rarely cross exactly perpendicular to the cutting plane, so if the same features are chosen for registration marks, the features may drift spatially across the sections and thus for example an object at an incline may be misconstrued as being vertical.
  • As disclosed herein, the post-processing of images may be improved because the post-processing of distortions may be performed on two images of the exact same section, one without distortions and one or more without. Since the images are of the same slice, the same exact registration marks will occur on all images, making the selection process easier and more consistent. The same phenomenon can also reduce spatial drift that would otherwise occur for cylindrical features traveling at an incline relative to the cutting plane. FIG. 1D1 and FIG. 1D2 illustrate how distortions occur employing the current state of the art (FIG. 1D1) in comparison to how image post-processing may be improved with regard to these distortions as disclosed herein (FIG. 1D2).
  • As shown in FIG. 1D1, an object 103 may be in present in the sample 101 which may be sliced into two slices 105A and 105B. Images 107A, 107B may be generated for each slice 105A, 105B, respectively, showing the object 103 at different depths.
  • As shown in FIG. 1D2, an object 103 may be present in the sample 101 which may be sliced into two slices 105A and 105B. Primary and secondary images may be generated for each of the slices 105A, 105B (such as primary image 109A1 and secondary image 109A2 for primary slice 105A, and primary image 109B1 and secondary image 109B2 for secondary slice 105B.)
  • Primary Imaging
  • As described herein, the first step in this method comprises a Primary Imaging (PI) step, which may capture a view of the section before processing or post-processing distortions. This may be accomplished by imaging the sample before slicing or by imaging during slicing. The primary imaging may be performed with a KESM, which may capture an un-warped image on the block face during the slicing operation. These images may be referred to as X_N. By incorporating this PI step, the Secondary Imaging (SI) step can have a direct anchor to the actual original shape and location of the slice, which may enable better registration and analysis of stain reactions of a sample. FIG. 2A is a diagram that illustrates the imaging steps for the spatial multiplexing method 200. The sample 101 may be imaged in a primary imaging step 211A before a thin section 221A is sliced from the sample 101. Further primary imaging steps 211B to 211N may be performed before further slicing the sample to further thin sections 221B to 221N. The primary images may be collected and registered with one another to generate a virtual thick slice 223.
  • As described herein, after the PI steps (221A, 221B, . . . 221N), the slice(s) may be mounted on a glass slide and antigen or protein stains may then be applied in a step 231 to the sample slices for further analysis.
  • Secondary Imaging
  • Another aspect of the disclosure includes a Secondary Imaging (SI) step(s) 241A, 241B, . . . 241N. In the SI steps, the KESM may be used to image the stained slices of the sample 101 after a stain or a full panel of stains 231 has been applied. These step(s) may be repeated as many times as is desired, re-imaging the slices each time a new stain is applied to the sample. These images will be referred to as Y_n.
  • Reconstruction
  • Another aspect of the disclosure describes a reconstruction step. In the reconstruction step, various computations may be employed to create a reconstructed image across different stained images. As shown in FIG. 2A, the secondary images may be collected and registered with one another to generate a stack of co-registered stains 243. The primary virtual thick slice 223 and the co-registered stack of stained slices 242 may be analyzed in a data-gathering or diagnosis step 251.
  • As described herein, a computational transformation of the Y_n images may be performed to reconstruct and spatially align the various sample slices to each other. The panel of stained Y_n images may be mapped back to the biomarker coordinates established by the X_n images by employing computational transformations. These remapped images will be referred to as Z_n. These computational transformations may include, but are not limited to:
      • a. “Procrustean” transformations, which may include stretch, shear, translation, rotation, and more general affine transformations to map visible variables or biomarkers across images.
      • b. “Elastic sheet” type transformations employing basis splines, or other non-linear interpolation schemes to map biomarkers by matching the curvature of the object, incorporating both affine and nonaffine transformations.
      • c. Optical-based corrections to account for the differences between the optics of the primary and secondary imaging. This can include perspective, barrel, pincushion, and chromatic corrections.
  • Co-Registration
  • Another aspect of the disclosure describes a co-registration step, wherein the images from the PI and SI steps captured by the KESM are compared and aligned to each other based on the mapped biomarkers established in the reconstruction step.
  • As described herein, the stack of Z_n images may be superimposed to co-register the different stains. This step may be repeated to complete a full panel of stains and compare the results based on the co-registered images. Methods for completing the co-registration step may include:
      • a. Side-by-side presentation, rendering, or image overlay of the Z_n images. FIG. 2B illustrates how the Primary images 261 and Secondary images 262 are co-registered using a side-by-side presentation method, and may be shown as a composite image 263.
      • b. Mathematical combination of several Z images to create a composite image or virtual “slice” capable of showing where different stains are present, and/or coincident. FIG. 2C illustrates how several images 271, 272, 273 may be combined to create a composite image 274 by mathematic combination.
    Further Embodiments
  • An additional embodiment of a workflow may be similar to the work flow 200 above, with an additional imaging step between the mounting and staining steps.
  • The above description(s) describes the treatment of a single slice in FIG. 2A. Using the primary imaging information, multiple slices may be aligned across the Z plane to the slices above and below within the sample. Using this anchoring, the workflows 100A, 100B, 100C described above may be replaced in the following ways:
      • The Anatomist Workflow 100A: All of the stains in the “stain-panel” can be made the same. Each stained slice may be linked back to its primary imaging, and the primary images to each other. This can both improve the quality of reconstruction, as well as minimize the fraction of human involvement.
      • The Histologist/Pathologist Workflow 100B: A large number of requested stains could be run independently within the panel. Each of these stained images may be again linked back to the primary imaging, and many layers/contrast agents may be linked back to the overall sample. This may minimize the number of iterations in which the medical professional would be involved, and lead to a quicker diagnosis, and faster turnaround on lab analyses.
      • The Biologist Workflow 100C: Several different stains could be repeated on interleaved layers. In this way stains could be multiplexed over the sample volume, and example including 3 stains labeled a, b, c might look like:
        • a|b|c|a|b|c|a|b|c|a|b|c|a|b|c|a|b|c
  • This multiplexing approach gives a larger 3D distribution of the labels across the volume while tethering each slice back to the overall block. Additionally, the stained information could be interpolated across adjacent sections.
  • These embodiments could also be augmented in any one of at least the following ways:
      • 1. Several channel images can be combined into one, creating a virtual multi-channel panel image
      • 2. The optimal sectioning thickness and number of stains can be determined by the features observed in the primary imaging, i.e. some features may be large, and thick sections may be appropriate, where other features are smaller and may necessitate thin sections.
      • 3. The entire panel does not have to be determined at once. The output of a first round of imaging could be used to determine the second round.
      • 4. Section thickness could be adjusted with respect to the stain chemistry, i.e. thinner or thicker sections can be cut for a multiplexed stain optimized for each particular contrast agent's properties.
      • 5. Every n'th slice might be treated differently, based on the primary imaging. This might include:
      • 6. Being sliced at a thickness optimal for the stain in question.
      • 7. Being diverted to a molecular diagnostic or other chemical assay.
      • 8. Be discarded based on an imaging or slicing defect or lack of sample in the slice.
      • 9. Be archived to comply with regulations.
      • 10. As above, but instead making the slice treatment decision based on the Primary Imaging step.
  • While preferred embodiments of the present disclosure have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the scope of the present disclosure. It should be understood that various alternatives to the embodiments of the present disclosure described herein may be employed in practicing the inventions of the present disclosure. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Claims (19)

What is claimed is:
1. A method of analyzing a sample, the method comprising:
slicing the sample into a plurality of sections;
for each section in the plurality of sections:
generating a primary image of the section;
associating the primary image with the section;
based on information from the primary image of the section, determining whether to stain the section;
based on a determination that the section is to be stained:
determining a staining agent to be used to stain the section using the information from the primary image of the section;
staining the section using the staining agent;
generating a secondary image of the section by imaging the stained section; and
associating the secondary image with the section.
2. The method of claim 1, wherein the sample comprises a tissue sample.
3. The method of claim 1, further comprising:
for each section in the plurality of sections having an associated primary image and an associated secondary image:
co-registering the associated primary image with the associated secondary image by post-processing the associated primary image having no distortions with the associated secondary image having distortions that occurred during the staining, thereby improving post-processing of images; and
wherein the post-processing includes processing distortions in the associated secondary image based on the associated primary image; and
co-registering the secondary images associated with the plurality of sections with one another.
4. The method of claim 1, further comprising:
generating a virtual model of the sample based on primary images associated with each section of the plurality of sections.
5. The method of claim 1, further comprising:
for each section in the plurality of sections having an associated primary image and an associated secondary image:
co-registering the associated primary image with the associated secondary image by post-processing the associated primary image having no distortions with the associated secondary image having distortions that occurred during the staining, thereby improving post-processing of images; and
wherein the post-processing includes processing distortions in the associated secondary image based on the associated primary image;
co-registering the secondary images associated with the plurality of sections with one another; and
co-registering the co-registered plurality of secondary images of the sample to the virtual model.
6. The method of claim 5, further comprising:
generating a diagnosis in response to the co-registration of the co-registered plurality of secondary images of the sample and the virtual model.
7. The method of claim 1, wherein slicing the sample into a plurality of sections comprises slicing a block face of the sample.
8. The method of claim 1, further comprising:
mounting the plurality of sections onto a plurality of slides.
9. The method of claim 1, wherein the staining agent is one of: an antigen or protein stain.
10. One or more non-transitory computer-readable storage media, storing one or more sequences of instructions, which when executed by one or more processors cause performance of:
slicing the sample into a plurality of sections;
for each section in the plurality of sections:
generating a primary image of the section;
associating the primary image with the section;
based on information from the primary image of the section, determining whether to stain the section;
based on a determination that the section is to be stained:
determining a staining agent to be used to stain the section using the information from the primary image of the section;
staining the section using the staining agent;
generating a secondary image of the section by imaging the stained section; and
associating the secondary image with the section.
11. The one or more non-transitory computer-readable storage media of claim 10, wherein the sample comprises a tissue sample.
12. The one or more non-transitory computer-readable storage media of claim 10, further comprising:
for each section in the plurality of sections having an associated primary image and an associated secondary image:
co-registering the associated primary image with the associated secondary image by post-processing the associated primary image having no distortions with the associated secondary image having distortions that occurred during the staining, thereby improving post-processing of images; and
wherein the post-processing includes processing distortions in the associated secondary image based on the associated primary image; and
co-registering the secondary images associated with the plurality of sections with one another.
13. The one or more non-transitory computer-readable storage media of claim 10, further comprising:
generating a virtual model of the sample based on primary images associated with each section of the plurality of sections.
14. The one or more non-transitory computer-readable storage media of claim 10, further comprising:
for each section in the plurality of sections having an associated primary image and an associated secondary image:
co-registering the associated primary image with the associated secondary image by post-processing the associated primary image having no distortions with the associated secondary image having distortions that occurred during the staining, thereby improving post-processing of images; and
wherein the post-processing includes processing distortions in the associated secondary image based on the associated primary image;
co-registering the secondary images associated with the plurality of sections with one another; and
co-registering the co-registered plurality of secondary images of the sample to the virtual model.
15. The one or more non-transitory computer-readable storage media of claim 14, further comprising generating a diagnosis in response to the co-registration of the co-registered plurality of secondary images of the sample and the virtual model.
16. The one or more non-transitory computer-readable storage media of claim 10, wherein slicing the sample into a plurality of sections comprises slicing a block face of the sample.
17. The one or more non-transitory computer-readable storage media of claim 10, further comprising:
mounting the plurality of sections onto a plurality of slides.
18. The one or more non-transitory computer-readable storage media of claim 10, wherein the staining agent is one of: an antigen or protein stain.
19. A method of analyzing a sample, the method comprising:
slicing the sample into a plurality of sections;
for each section in the plurality of sections:
generating a primary image of the section;
associating the primary image with the section; and
based on information from the primary image of the section, diverting the section to a molecular diagnostic.
US16/950,870 2015-07-10 2020-11-17 Spatial multiplexing of histological stains Abandoned US20210073980A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/950,870 US20210073980A1 (en) 2015-07-10 2020-11-17 Spatial multiplexing of histological stains

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562190931P 2015-07-10 2015-07-10
US15/205,288 US10839509B2 (en) 2015-07-10 2016-07-08 Spatial multiplexing of histological stains
US16/950,870 US20210073980A1 (en) 2015-07-10 2020-11-17 Spatial multiplexing of histological stains

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/205,288 Continuation US10839509B2 (en) 2015-07-10 2016-07-08 Spatial multiplexing of histological stains

Publications (1)

Publication Number Publication Date
US20210073980A1 true US20210073980A1 (en) 2021-03-11

Family

ID=56802211

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/205,288 Expired - Fee Related US10839509B2 (en) 2015-07-10 2016-07-08 Spatial multiplexing of histological stains
US16/950,870 Abandoned US20210073980A1 (en) 2015-07-10 2020-11-17 Spatial multiplexing of histological stains

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/205,288 Expired - Fee Related US10839509B2 (en) 2015-07-10 2016-07-08 Spatial multiplexing of histological stains

Country Status (6)

Country Link
US (2) US10839509B2 (en)
EP (1) EP3115766A1 (en)
JP (1) JP6841609B2 (en)
KR (1) KR20170007181A (en)
CN (1) CN106338423B (en)
TW (1) TW201709150A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11239050B2 (en) 2017-10-16 2022-02-01 Hitachi High-Tech Corporation Imaging device
JP7308848B2 (en) * 2018-02-12 2023-07-14 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト Conversion of digital pathological images
US10915729B2 (en) 2018-02-20 2021-02-09 The Regents Of The University Of Michigan Three-dimensional cell and tissue image analysis for cellular and sub-cellular morphological modeling and classification
US11783603B2 (en) 2018-03-07 2023-10-10 Verily Life Sciences Llc Virtual staining for tissue slide images
JP2021534509A (en) * 2018-08-22 2021-12-09 ユニバーシティ オブ ピッツバーグ−オブ ザ コモンウェルス システム オブ ハイヤー エデュケーションUniversity Of Pittsburgh Of The Commonwealth System Of Higher Education Spatically co-registered genomic and imaging (SCORGI) data elements for fingerprinting microdomains
CN113614506B (en) * 2019-03-19 2025-02-14 微视股份有限公司 Automated systems and methods for tissue sectioning, staining and scanning
EP3983803A2 (en) * 2019-06-14 2022-04-20 Akoya Biosciences, Inc. Multiplexed tissue imaging
EP3987481B1 (en) * 2019-06-18 2025-09-17 SurgVision GmbH Luminescence imaging with refining loop based on combination of partial illuminations
JP2024538518A (en) * 2021-09-16 2024-10-23 コリア アドバンスド インスティチュート オブ サイエンス アンド テクノロジィ Apparatus and method for processing images

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050062897A1 (en) * 2003-08-01 2005-03-24 Zhichun Lei Method for pre-processing image data
US20140228707A1 (en) * 2013-02-11 2014-08-14 Definiens Ag Coregistering Images of Needle Biopsies Using Multiple Weighted Landmarks
US20150287194A1 (en) * 2013-02-11 2015-10-08 Definiens Ag Updating Landmarks to Improve Coregistration as Regions of Interest are Corrected

Family Cites Families (463)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE382501B (en) 1975-04-10 1976-02-02 Lkb Produkter Ab PROCEDURE TO KNOW A MICROTOM FORA THE KNIFE NEXT TO THE PREPARATION.
SE431682B (en) 1982-06-28 1984-02-20 Lkb Produkter Ab PROCEDURE TO MAKE THE EXTREMELY SMALL BETWEEN KNIFE OIL AND PREPARATION BY A MICROTOM
US4697489A (en) 1984-07-05 1987-10-06 Kim George A Ultramicrotome tool
US4581969A (en) 1984-07-05 1986-04-15 Kim George A Ultramicrotome diamond knife
AT399226B (en) * 1990-04-11 1995-04-25 Sitte Hellmuth AUTOMATIC CUTTING DEVICE FOR MICROTOMES, IN PARTICULAR ULTRAMICROTOMAS
AT399227B (en) 1990-04-11 1995-04-25 Sitte Hellmuth DEVICE FOR CONTROLLING THE DRIVE AND THE FEED OF A MICROTOM, IN PARTICULAR ULTRAMICROTOMA
US5282404A (en) 1990-11-09 1994-02-01 The Government Of The United States Of America As Represented By The Secretary Of The Dept. Of Health & Human Services Microtome with micro-plane and electric contact reference
US6774117B1 (en) 1992-03-11 2004-08-10 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6180061B1 (en) 1992-05-11 2001-01-30 Cytologix Corporation Moving platform slide stainer with heating elements
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5461953A (en) 1994-03-25 1995-10-31 Mccormick; James B. Multi-dimension microtome sectioning device
US6169169B1 (en) 1994-05-19 2001-01-02 Dako A/S PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis
US5696917A (en) 1994-06-03 1997-12-09 Intel Corporation Method and apparatus for performing burst read operations in an asynchronous nonvolatile memory
US5920319A (en) 1994-10-27 1999-07-06 Wake Forest University Automatic analysis in virtual endoscopy
US5752425A (en) 1995-12-25 1998-05-19 Chuo Precision Industrial Co., Ltd. Microtome
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
DE19633436A1 (en) 1996-08-20 1998-02-26 Boehringer Mannheim Gmbh Method for the detection of nucleic acids by determining the mass
WO1998015648A1 (en) 1996-10-04 1998-04-16 Dako A/S Novel probes for the detection of mycobacteria
US6110676A (en) 1996-12-04 2000-08-29 Boston Probes, Inc. Methods for suppressing the binding of detectable probes to non-target sequences in hybridization assays
US5978833A (en) 1996-12-31 1999-11-02 Intel Corporation Method and apparatus for accessing and downloading information from the internet
US8545569B2 (en) 2001-05-25 2013-10-01 Conformis, Inc. Patient selectable knee arthroplasty devices
DE19712530A1 (en) 1997-03-25 1998-10-01 Boehringer Mannheim Gmbh New monomer building blocks for labeling peptidic nucleic acids
DE69831113T2 (en) 1997-05-30 2006-05-24 Pna Diagnostics A/S 2-OR 3-DIMENSIONAL GEOMETRIC STRUCTURE OF PEPTIDE NUCLEIC ACIDS
US5895871A (en) 1997-07-25 1999-04-20 General Electric Company Finger controlled inspection apparatus
US20110290899A1 (en) 1997-10-15 2011-12-01 Petrovich Svetozar B GC boundaries
DE69838484T2 (en) 1997-11-03 2008-06-26 Asm America Inc., Phoenix HIGH-TEMPERATURE PROCESS CHAMBER WITH LONG SERVICE LIFE
US6183693B1 (en) 1998-02-27 2001-02-06 Cytologix Corporation Random access slide stainer with independent slide heating regulation
US6287772B1 (en) 1998-04-29 2001-09-11 Boston Probes, Inc. Methods, kits and compositions for detecting and quantitating target sequences
JP2002513587A (en) 1998-05-04 2002-05-14 ダコ エー エス Methods and probes for detecting chromosomal abnormalities
US6142019A (en) 1998-06-29 2000-11-07 General Electric Co. Method of determining surface acoustic wave paths
US6573043B1 (en) 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
US6196221B1 (en) 1999-02-08 2001-03-06 Polar Wrap, Llc Thermal exchange breathing device
US6112332A (en) 1999-03-12 2000-09-05 Polarwrap, Llc Insulated liner for headgear
US6673620B1 (en) 1999-04-20 2004-01-06 Cytologix Corporation Fluid exchange in a chamber on a microscope slide
JP3604593B2 (en) 1999-06-28 2004-12-22 東芝機械株式会社 Thin sample preparation equipment
JP2003503591A (en) 1999-06-29 2003-01-28 ダコ エー エス Detection using dendrimers carrying labels and probes
CA2376969A1 (en) 1999-07-21 2001-02-01 Dako A/S A method of controlling the temperature of a specimen in or on a solid support member
US6176135B1 (en) 1999-07-27 2001-01-23 Marc Dubois System and method for laser-ultrasonic frequency control using optimal wavelength tuning
US6335943B1 (en) 1999-07-27 2002-01-01 Lockheed Martin Corporation System and method for ultrasonic laser testing using a laser source to generate ultrasound having a tunable wavelength
US7024316B1 (en) 1999-10-21 2006-04-04 Dakocytomation Colorado, Inc. Transiently dynamic flow cytometer analysis system
US7374907B1 (en) 2000-04-07 2008-05-20 John Voneiff System and method for automatically processing tissue samples
DE50107916D1 (en) 2000-05-31 2005-12-08 Fraunhofer Ges Forschung THREE-DIMENSIONAL SKIN MODEL
US8548745B2 (en) 2000-06-08 2013-10-01 The Regents Of The University Of California Visual-servoing optical microscopy
US6684701B2 (en) 2000-07-14 2004-02-03 Lockheed Martin Corporation System and method of determining porosity in composite materials using ultrasound
US7613571B2 (en) 2000-07-28 2009-11-03 Doyle Michael D Method and system for the multidimensional morphological reconstruction of genome expression activity
CN1498385A (en) 2000-08-29 2004-05-19 Method and device for measuring and analyzing X-ray images
US6744572B1 (en) * 2000-09-06 2004-06-01 The Texas A&M University System System and method for imaging an object
US7060802B1 (en) 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
US7699790B2 (en) 2000-12-20 2010-04-20 Ev3, Inc. Debulking catheters and methods
US20020132274A1 (en) 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
US6681073B2 (en) 2001-03-19 2004-01-20 Molecular Optoelectronics Corporation Fiber optic power control systems and methods
US6727072B2 (en) 2001-05-01 2004-04-27 Dako Corporation EGF-r detection kit
WO2002092247A1 (en) 2001-05-17 2002-11-21 Cytomation, Inc. Flow cytometer with active automated optical alignment system
EP1389980B1 (en) 2001-05-25 2011-04-06 Conformis, Inc. Methods and compositions for articular resurfacing
US7667851B2 (en) 2001-07-24 2010-02-23 Lockheed Martin Corporation Method and apparatus for using a two-wave mixing ultrasonic detection in rapid scanning applications
US6458598B1 (en) 2001-08-13 2002-10-01 Dako A/S Process for preparing and presenting a tissue sample for histological study
US6668654B2 (en) 2001-08-15 2003-12-30 Lockheed Martin Corporation Method and apparatus for generating specific frequency response for ultrasound testing
US6649900B2 (en) 2001-09-07 2003-11-18 Lockheed Martin Corporation Photoreceiver assembly for high-powered lasers
US7039362B2 (en) 2001-09-27 2006-05-02 General Electric Company Wireless transceiver and method for remote ultrasonic measurements
US7117134B2 (en) 2001-10-18 2006-10-03 Lockheed Martin Corporation Method to optimize generation of ultrasound using mathematical modeling for laser ultrasound inspection
US7771662B2 (en) 2001-10-19 2010-08-10 Hologic, Inc Vial system and method for processing liquid-based specimens
DE10154843A1 (en) 2001-11-08 2003-05-28 Microm Int Gmbh Method and device for labeling slides for microtomized tissue samples and their processing
US8676509B2 (en) 2001-11-13 2014-03-18 Dako Denmark A/S System for tracking biological samples
US6856918B2 (en) 2001-11-26 2005-02-15 Lockheed Martin Corporation Method to characterize material using mathematical propagation models and ultrasonic signal
JP3576136B2 (en) 2001-11-30 2004-10-13 堂阪イーエム株式会社 Test piece cutting device
US20050044732A1 (en) 2002-01-14 2005-03-03 Mccormick Bruce Garment fitting system
US6813838B2 (en) 2002-01-14 2004-11-09 Mccormick Bruce Garment fitting system
US6732587B2 (en) 2002-02-06 2004-05-11 Lockheed Martin Corporation System and method for classification of defects in a manufactured object
CN101219058B (en) 2002-03-14 2012-01-11 Netkisr有限公司 System and method for analyzing and displaying computed tomography data
US7569675B2 (en) 2002-09-11 2009-08-04 Spring Bioscience Corporation High affinity monoclonal antibody for recognizing the progesterone receptor (PR) and method for creating the antibody
BR0215894B1 (en) 2002-09-26 2012-11-27 tissue sample retention cassette, tissue sample embedding assembly prior to microtomy procedure, tissue sample cassette staggering device and cassette cutting method.
US7873223B2 (en) 2002-10-15 2011-01-18 Definiens Ag Cognition integrator and language
AU2003284885A1 (en) 2002-10-21 2004-05-13 Kensey Nash Corporation Device and methods for sequential, regional delivery of multiple cytotoxic agents
US6744575B1 (en) * 2002-11-12 2004-06-01 Axon Instruments, Inc. Optical mount and method for use thereof
US6927686B2 (en) 2002-12-11 2005-08-09 General Electric Company Method and apparatus for internet enabled, wireless remote sensor measurement
AU2002353671A1 (en) 2002-12-17 2004-07-09 Ljung Tech As A staining machine for treatment of tissue specimens
US7875245B2 (en) 2003-05-14 2011-01-25 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US7648678B2 (en) 2002-12-20 2010-01-19 Dako Denmark A/S Method and system for pretreatment of tissue slides
US6711312B1 (en) 2002-12-20 2004-03-23 General Electric Company Integrated optoelectronic circuit and method of fabricating the same
US7584019B2 (en) 2003-12-15 2009-09-01 Dako Denmark A/S Systems and methods for the automated pre-treatment and processing of biological samples
US7850912B2 (en) 2003-05-14 2010-12-14 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US6710912B1 (en) 2002-12-23 2004-03-23 General Electric Company Technique for quasi-phase matching
US7327022B2 (en) 2002-12-30 2008-02-05 General Electric Company Assembly, contact and coupling interconnection for optoelectronics
JP2004219261A (en) 2003-01-15 2004-08-05 Fuji Photo Film Co Ltd Thin film analysis method
DE602004022508D1 (en) 2003-01-16 2009-09-24 Gen Hospital Corp USE OF THREE-DIMENSIONAL, MICRO-MANUFACTURED SYSTEMS FOR PHARMACOLOGICAL APPLICATIONS MANUFACTURED BY TISSUE TECHNOLOGY
US7257268B2 (en) 2003-02-28 2007-08-14 Aperio Technologies, Inc. Systems and methods for image pattern recognition
US7571728B2 (en) 2003-04-10 2009-08-11 Xoft, Inc. Gross pathology breast map
US8283176B2 (en) 2004-06-29 2012-10-09 Dako Denmark A/S Method of pre-treatment and staining of a biological sample and device for support of a biological sample and methods of using such device
US8249813B2 (en) 2003-05-22 2012-08-21 Brainlab Ag System and process for metabolic guidance of introduced cellular material
EP1631388A4 (en) 2003-06-09 2007-09-05 Dako Denmark As Diaphram metering chamber dispensing systems
HUP0301911A2 (en) 2003-06-24 2005-03-29 3Dhistech Kft. Base board feeding device for automated scanning microscope
US20050018748A1 (en) 2003-07-24 2005-01-27 Ringermacher Harry Israel Actively quenched lamp, infrared thermography imaging system, and method for actively controlling flash duration
WO2005020790A2 (en) 2003-08-21 2005-03-10 Ischem Corporation Automated methods and systems for vascular plaque detection and analysis
US8043614B2 (en) 2004-03-09 2011-10-25 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
KR101242260B1 (en) 2003-09-11 2013-03-13 휴비트 제노믹스 가부시키가이샤 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis
DE10342264C5 (en) 2003-09-12 2012-10-31 Leica Biosystems Nussloch Gmbh System for uniquely assigning histological cassettes and slides
WO2005033333A2 (en) 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
US7778493B2 (en) 2003-10-09 2010-08-17 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Inc. Pixelation reconstruction for image resolution and image data transmission
US20050098445A1 (en) 2003-11-10 2005-05-12 General Electric Company Electrochemical machining method, tool assembly, and monitoring method
WO2005057436A1 (en) 2003-11-14 2005-06-23 Drexel University Method and apparatus for computer-aided tissue engineering for modeling, design and freeform fabrication of tissue scaffolds, constructs, and devices
AU2004295699A1 (en) 2003-12-01 2005-06-16 Dako Denmark A/S Methods and compositions for immuno-histochemical detection
US20070248924A1 (en) 2003-12-10 2007-10-25 Torstein Ljungmann Apparatus for treatment of tissue specimens
ITRM20030572A1 (en) 2003-12-11 2005-06-12 Fond Telethon USE OF H-PRUNE ENZYMATIC INHIBITORS FOR THE PREVENTION AND TREATMENT OF METASTASES OF H-PRUNE EXPERIENCED TUMORS.
US20050136333A1 (en) 2003-12-19 2005-06-23 Lawrence Brian L. Novel optical storage materials based on narrowband optical properties
US7653229B2 (en) 2003-12-23 2010-01-26 General Electric Company Methods and apparatus for reconstruction of volume data from projection data
JP4745984B2 (en) 2004-01-08 2011-08-10 ダコ デンマーク アクティーゼルスカブ Apparatus and method for processing biological samples and reservoir for the same
WO2005069223A2 (en) 2004-01-15 2005-07-28 Algotec Systems Ltd. Vessel centerline determination
CA2457171A1 (en) 2004-02-09 2005-08-09 Centre Hospitalier De L'universite De Montreal - Chum Imaging apparatus and methods
JP5189294B2 (en) 2004-02-13 2013-04-24 エーエスエム アメリカ インコーポレイテッド Substrate support system for reducing autodoping and backside deposition
JP4848355B2 (en) 2004-02-27 2011-12-28 アンスティテュ・キュリ Novel growth markers in clinical practice and their use for cancer prognosis or diagnosis
JP2007526479A (en) 2004-03-02 2007-09-13 ダコ デンマーク アクティーゼルスカブ Reagent delivery system, dispensing device and container for biological staining apparatus
SE0400731D0 (en) 2004-03-22 2004-03-22 Contextvision Ab Method, computer program product and apparatus for enhancing a computerized tomography image
US7367945B2 (en) 2004-03-29 2008-05-06 General Electric Company Ultrasound system
US20050213710A1 (en) 2004-03-29 2005-09-29 Lawrence Brian L System and method for laser X-ray generation
US7016470B2 (en) 2004-03-29 2006-03-21 General Electric Company System and method for X-ray generation
US7411991B2 (en) 2004-03-31 2008-08-12 General Electric Company Tunable laser
USRE46379E1 (en) 2004-04-08 2017-04-25 Cornell Research Foundation, Inc. Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
US7306916B2 (en) 2004-05-04 2007-12-11 Dako Denmark A/S Methods for detecting chromosome aberrations
CA2571229C (en) 2004-06-19 2012-11-27 Bruce Mccormick An insulating liner for an article of clothing
US20060254088A1 (en) 2004-06-19 2006-11-16 Mccormick Bruce Thermal liner for an article of clothing
CN101001647A (en) 2004-07-08 2007-07-18 塞勒克塔有限公司 Virtual colonoscopy with radiolabeled phospholipid ether analogs
US7867443B2 (en) 2004-07-23 2011-01-11 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
DE102004037512B4 (en) 2004-08-03 2012-11-08 Bruker Daltonik Gmbh Mass spectrometric tissue state differentiation
HUP0401802A2 (en) 2004-09-02 2006-03-28 3D Histech Kft Focusing method object carriers on fast-moving digitalization and object carrier moving mechanics, focusing optic, optical distance-measuring instrument
GB0420657D0 (en) 2004-09-16 2004-10-20 Thermo Shandon Ltd Cryostat and microtome
HUP0401870A2 (en) 2004-09-17 2006-04-28 3D Histech Kft Method and computer program product for storing high volume coherent primarily 3d information assuring fast retrieval and transmission
DK1794586T3 (en) 2004-09-22 2013-05-13 Cancer Advances Inc Monoclonal antibodies to progastrin
US7123393B2 (en) 2004-09-28 2006-10-17 General Electric Company Method and apparatus for holographic recording and retrieval
US8515200B2 (en) 2004-10-29 2013-08-20 New York University System, software arrangement and method for segmenting an image
US7558417B2 (en) 2004-11-29 2009-07-07 General Electric Company Method and apparatus for analyzing three-dimensional images containing voxels
US8064663B2 (en) 2004-12-02 2011-11-22 Lieven Van Hoe Image evaluation system, methods and database
SG123615A1 (en) 2004-12-10 2006-07-26 Nanyang Polytechnic Method for designing 3-dimensional porous tissue engineering scaffold
NO321927B1 (en) 2004-12-23 2006-07-24 Oystein Ljungmann Apparatus for performing treatment operations on slides with tissue samples
NO20045625D0 (en) 2004-12-23 2004-12-23 Torstein Ljungmann Slide holding device with tissue samples
NO321928B1 (en) 2004-12-23 2006-07-24 Oystein Ljungmann Method and system for using treatment liquids in an apparatus for staining tissue samples on slides
US7110192B2 (en) 2005-01-12 2006-09-19 Dako Denmark A/S System and method for a composite lens for a flow cytometer
WO2006082192A1 (en) 2005-02-03 2006-08-10 Bracco Imaging S.P.A. Method and computer program product for registering biomedical images with reduced imaging arefacts caused by object movement
DE102005005007B3 (en) 2005-02-03 2006-09-07 Lts Lohmann Therapie-Systeme Ag Biopsy needle for histological examination of body tissue
US7646902B2 (en) 2005-02-08 2010-01-12 Regents Of The University Of Michigan Computerized detection of breast cancer on digital tomosynthesis mammograms
WO2006090283A2 (en) 2005-02-25 2006-08-31 Dako Denmark A/S Cell counting
US20100196509A1 (en) 2005-02-28 2010-08-05 Jonathan Braun Methods for Diagnosis and Treatment of Endometrial Cancer
US20120029358A1 (en) 2005-03-03 2012-02-02 Sonowise, Inc. Three -Dimensional Ultrasound Systems, Methods, and Apparatuses
JP5199866B2 (en) 2005-03-23 2013-05-15 メイヨ フオンデーシヨン フオー メデイカル エジユケーシヨン アンド リサーチ Photocrosslinkable oligo (poly (ethylene glycol) fumarate) hydrogels for cell and drug delivery
US7310408B2 (en) 2005-03-31 2007-12-18 General Electric Company System and method for X-ray generation by inverse compton scattering
US7599542B2 (en) 2005-04-08 2009-10-06 John Philip Brockway System and method for detection and display of diseases and abnormalities using confidence imaging
US7995809B2 (en) 2005-04-18 2011-08-09 Siemens Medical Solutions Usa, Inc. Refined segmentation of nodules for computer assisted diagnosis
SG2014011837A (en) 2005-04-18 2014-04-28 Mitomics Inc Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
US20110045459A1 (en) 2005-04-21 2011-02-24 Mischel Paul S Molecular determinants of EGFR kinase inhibitor response in glioblastoma
DK1877101T3 (en) 2005-04-28 2017-01-09 Ventana Med Syst Inc ENZYMES CONJUGATED TO ANTIBODIES THROUGH A PEG hetero LINKER
EP1893241A2 (en) 2005-04-28 2008-03-05 Ventana Medical Systems, Inc. Fluorescent nanoparticles conjugated to antibodies via a peg linker
US20090128145A1 (en) 2005-05-19 2009-05-21 Shepherd Timothy M Apparatus and method for obtaining magnetic resonance imaging or spectroscopy data from live tissue samples
JP5166250B2 (en) 2005-05-25 2013-03-21 エクスプレッション、パソロジー、インコーポレイテッド Multiplex method using liquid tissue preparations to increase the coverage of proteome from histopathologically processed biological samples
US7893934B2 (en) 2005-05-26 2011-02-22 The Board Of Regents Of The University Of Oklahoma Three-dimensional finite element modeling of human ear for sound transmission
FR2886433B1 (en) 2005-05-30 2007-09-07 Commissariat Energie Atomique METHOD FOR SEGMENTATING A SEQUENCE OF THREE-DIMENSIONAL IMAGES, IN PARTICULAR IN PHARMACO-IMAGING.
DE602006016106D1 (en) 2005-05-31 2010-09-23 Dako Denmark As COMPOSITIONS AND METHOD FOR PREDICTING THE OUTPUT OF TREATMENT
US20070015992A1 (en) 2005-06-30 2007-01-18 General Electric Company System and method for optoacoustic imaging
WO2007031874A2 (en) 2005-07-01 2007-03-22 Dako Denmark A/S Method of simultaneously visualizing multiple biological targets
US9017992B2 (en) 2005-07-01 2015-04-28 Dako Denmark A/S In situ hybridization detection method
EP1744181B8 (en) 2005-07-15 2014-04-09 Kabushiki Kaisha Toshiba Ultrasonic diagnostic apparatus and ultrasonic image processing method
US7899624B2 (en) 2005-07-25 2011-03-01 Hernani Del Mundo Cualing Virtual flow cytometry on immunostained tissue-tissue cytometer
US20070025917A1 (en) 2005-07-26 2007-02-01 General Electric Company Optical imaging based on locally activated bioluminescence
FR2891052B1 (en) 2005-09-21 2007-12-21 Histolex Soc Responsabilite Li PROCESS FOR PREPARING A SAMPLE
US7835784B2 (en) 2005-09-21 2010-11-16 Medtronic Navigation, Inc. Method and apparatus for positioning a reference frame
PT1934607E (en) 2005-10-13 2013-11-13 Fundacao D Anna Sommer Champalimaud E Dr Carlos Montez Champalimaud IMMUNO-HISTOQUÍMICA ANALYSIS IN SITU MULTIPLEX
US7831075B2 (en) 2005-10-20 2010-11-09 Case Western Reserve University Imaging system
EP1780651A1 (en) 2005-10-25 2007-05-02 Bracco Imaging, S.P.A. Method and system for automatic processing and evaluation of images, particularly diagnostic images
EP1780672A1 (en) 2005-10-25 2007-05-02 Bracco Imaging, S.P.A. Method of registering images, algorithm for carrying out the method of registering images, a program for registering images using the said algorithm and a method of treating biomedical images to reduce imaging artefacts caused by object movement
WO2007054326A1 (en) 2005-11-10 2007-05-18 Pamgene B.V. Method for assaying enzyme activity in histological sample
US20100278405A1 (en) 2005-11-11 2010-11-04 Kakadiaris Ioannis A Scoring Method for Imaging-Based Detection of Vulnerable Patients
US8634629B2 (en) 2005-11-11 2014-01-21 Hologic, Inc. Estimating risk of future bone fracture utilizing three-dimensional bone density model
WO2007059779A2 (en) 2005-11-28 2007-05-31 Dako Denmark A/S Cyanine dyes and methods for detecting a target using said dyes
US9114252B2 (en) 2005-12-02 2015-08-25 University Of Rochester Image-guided therapy delivery and diagnostic needle system
DE102005058095A1 (en) 2005-12-05 2007-06-06 Forschungszentrum Jülich GmbH Method for the topographic representation of changes in a studied brain
US8077945B2 (en) 2005-12-14 2011-12-13 The University Of Tokyo Method of analyzing cell or the like having linear shape, method of analyzing nerve cell and apparatus and program for performing these methods
US9095549B2 (en) 2005-12-16 2015-08-04 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
JP4933563B2 (en) 2005-12-19 2012-05-16 ヴェンタナ メディカル システムズ, インコーポレイテッド Automatic lean method in anatomical pathology
US8047990B2 (en) 2006-01-19 2011-11-01 Burdette Everette C Collagen density and structural change measurement and mapping in tissue
NO20060555L (en) 2006-02-02 2007-08-03 Torstein Ljungmann Apparatus for performing treatment operations in connection with staining of tissue samples on slides
US7975586B2 (en) 2006-02-06 2011-07-12 Leica Biosystems Richmond, Inc. Microtome and method of reversibly altering a microtome
JP4548356B2 (en) 2006-02-13 2010-09-22 セイコーインスツル株式会社 Automatic thin section specimen preparation device and automatic thin section specimen preparation method
US7989207B2 (en) 2006-02-17 2011-08-02 Tyco Healthcare Group Lp Testing lumenectomy samples for markers of non-vascular diseases
HUP0600177A2 (en) 2006-03-03 2009-03-02 3D Histech Kft Equipment for and method of digitizing slides by automated digital image recording system
NL1033301C1 (en) 2006-03-15 2007-09-18 Milabs B V Gamma image detection device.
ITTO20060223A1 (en) 2006-03-24 2007-09-25 I Med S R L PROCEDURE AND SYSTEM FOR THE AUTOMATIC RECOGNITION OF PRENEOPLASTIC ANOMALIES IN ANATOMICAL STRUCTURES, AND RELATIVE PROGRAM FOR PROCESSOR
US7943225B2 (en) 2006-03-27 2011-05-17 Polar Wrap, Llc Vented insulating liner method and apparatus
EP2002014A1 (en) 2006-04-01 2008-12-17 Dako Denmark A/S Method for performing prognoses for high-risk breast cancer patients using top2a gene aberrations
CN101410060A (en) 2006-04-03 2009-04-15 皇家飞利浦电子股份有限公司 Determining tissue surrounding an object being inserted into a patient
WO2007124151A2 (en) 2006-04-21 2007-11-01 The Trustees Of The University Of Pennsylvania Rapid 3-dimensional bilateral breast mr imaging
US8367351B2 (en) 2006-05-05 2013-02-05 Historx, Inc. Methods for determining signal transduction activity in tumors
WO2007132487A1 (en) 2006-05-15 2007-11-22 Im3D S.P.A. Method and system for automatic recognition of preneoplastic anomalies in anatomic structures based on an improved region-growing segmentation, and computer program therefor
US8425418B2 (en) 2006-05-18 2013-04-23 Eigen, Llc Method of ultrasonic imaging and biopsy of the prostate
WO2007137272A2 (en) 2006-05-22 2007-11-29 10H, Inc. Device and methods for preparing microscopy samples
US20100233132A1 (en) 2006-05-25 2010-09-16 Massachusetts Institute Of Technology Formation of vascular networks using embryonic stem cells
HUP0600435A2 (en) 2006-05-26 2007-11-28 3Dhistech Kft Method and system for digitizing a specimen having fluorescent target points
JP4745133B2 (en) 2006-05-30 2011-08-10 株式会社東芝 Ultrasonic diagnostic apparatus, medical image processing apparatus, and medical image processing program
US8535677B2 (en) 2006-06-06 2013-09-17 Oxford Biotherapeutics, Ltd. Antibody drug conjugate treatment of colorectal cancer
GB0611116D0 (en) 2006-06-06 2006-07-19 Oxford Genome Sciences Uk Ltd Proteins
WO2008026008A1 (en) 2006-08-29 2008-03-06 Oxford Genome Sciences (Uk) Ltd Protein
US7805183B2 (en) 2006-06-22 2010-09-28 Wisconsin Alumni Research Foundation Stromal collagen in the diagnosis and characterization of breast cancer
WO2008011437A1 (en) 2006-07-18 2008-01-24 Bristol-Myers Squibb Company Gamma secretase notch biomarkers
US20080032321A1 (en) 2006-08-07 2008-02-07 General Electric Company System and methods for analyzing images of tissue samples
US8060348B2 (en) 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
EP2559454A1 (en) 2006-09-26 2013-02-20 Sapiens Steering Brain Stimulation B.V. Tissue stimulation apparatus
DE102006048834A1 (en) 2006-10-16 2008-04-17 Rust, Georg-Friedemann, Dr. Three-dimensional measuring data set representing method for e.g. virtual coloscopy, involves selecting value of orientation parameter by controller to determine orientation of presentation plane with respect to another presentation plane
EP1913869A3 (en) 2006-10-19 2008-12-10 Esaote S.p.A. Diagnostic imaging method and apparatus for the anatomical region of the pelvic floor
SG142186A1 (en) 2006-10-20 2008-05-28 Agency Science Tech & Res Breast tumour grading
US20100323907A1 (en) 2006-10-27 2010-12-23 Long Ai Ton-That Frozen cell and tissue microarrays
US7741045B2 (en) 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
US7629125B2 (en) 2006-11-16 2009-12-08 General Electric Company Sequential analysis of biological samples
US8150192B2 (en) 2006-11-27 2012-04-03 Merge Cad Inc. System and method for feature score mapping and visualization of medical images
AU2007332770B2 (en) 2006-12-12 2013-09-05 Biopath Automation, L.L.C. Biopsy support with sectionable resilient cellular material
US20080144167A1 (en) 2006-12-13 2008-06-19 General Electric Company Optical imaging system and method for high speed and high resolution
WO2008071194A1 (en) 2006-12-15 2008-06-19 Aarhus Universitet Method for unbiased estimation of the total amount of objects based on non uniform sampling with probability obtained by using image analysis
US20100016765A1 (en) 2006-12-21 2010-01-21 Koninklijke Philips Electronics N.V. Integrated spect imaging and ultrasound therapy system
EP2122324B1 (en) 2007-02-09 2012-04-04 Dako Denmark A/S Horizontal antigen retrieval
WO2008100555A2 (en) 2007-02-14 2008-08-21 Drexel University Engineered lung tissue construction for high throughput toxicity screening and drug discovery
US7853089B2 (en) 2007-02-27 2010-12-14 The Board Of Trustees Of The University Of Arkansas Image processing apparatus and method for histological analysis
EP2129397B1 (en) 2007-03-02 2018-10-31 Amgen, Inc. Methods and compositions for treating tumor diseases
JP4559501B2 (en) 2007-03-14 2010-10-06 富士フイルム株式会社 Cardiac function display device, cardiac function display method and program thereof
DE102007013060A1 (en) 2007-03-19 2008-09-25 Siemens Ag Method for setting a B1 field
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
US20100043612A1 (en) 2007-04-20 2010-02-25 Feather Safety Razor Co., Ltd. Replaceable blade for microtome and curl prevention plate
US7576307B2 (en) 2007-04-30 2009-08-18 General Electric Company Microscope with dual image sensors for rapid autofocusing
US8179432B2 (en) 2007-04-30 2012-05-15 General Electric Company Predictive autofocusing
WO2008141293A2 (en) 2007-05-11 2008-11-20 The Board Of Regents Of The University Of Oklahoma One Partner's Place Image segmentation system and method
JP2010528613A (en) 2007-05-29 2010-08-26 クリストファー ビー. リード, Methods for producing pluripotent cell populations and uses thereof
JP5350369B2 (en) 2007-05-31 2013-11-27 ダコ デンマーク アクティーゼルスカブ Use of ESR copy number change in breast cancer treatment and prognosis
HUP0700404A2 (en) 2007-06-08 2009-03-30 3D Histech Kft Catch frame for slide and slide feeding unit
HU0700409D0 (en) 2007-06-11 2007-08-28 3D Histech Kft Method and system for accessing a slide from a remote workstation
EP3620465B1 (en) 2007-07-03 2025-02-19 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
KR20100105829A (en) 2007-07-17 2010-09-30 히스톨로직스 엘엘씨 Frictional trans-epithelial tissue disruption and collection apparatus and method of inducing and/or augmenting an immune response
US8041147B2 (en) 2007-07-18 2011-10-18 3DHISTECH Kft; Method for realistic stitching image blocks of an electronically recorded multipart image
EP2191414B1 (en) 2007-08-17 2019-02-13 CDx Medical IP, Inc. Feature dependent extended depth of focusing on semi-transparent biological specimens
WO2009026587A1 (en) 2007-08-23 2009-02-26 Fischer Medical Technologies, Inc. Improved computed tomography breast imaging and biopsy system
US20090052498A1 (en) 2007-08-24 2009-02-26 Asm America, Inc. Thermocouple
WO2009027525A2 (en) 2007-08-29 2009-03-05 Vito Nv Method for producing a three-dimensional macroporous filament construct based on phase inversion and construct thereby obtained
US8110159B2 (en) 2007-08-31 2012-02-07 Gooch And Housego Plc AOTF-based imaging system and method for hyperspectral and multispectral imaging of specimens including medical tissue
US9377465B2 (en) 2007-09-18 2016-06-28 Dako Denmark A/S Rapid and sensitive method for detection of biological targets
WO2009042644A2 (en) 2007-09-25 2009-04-02 Perception Raisonnement Action En Medecine Methods and apparatus for assisting cartilage diagnostic and therapeutic procedures
US8275182B2 (en) 2007-09-27 2012-09-25 The University Of British Columbia University-Industry Liaison Office Method for automated delineation of contours of tissue in medical images
EP2197908A2 (en) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
GB0719231D0 (en) 2007-10-03 2007-11-14 Oxford Genome Sciences Uk Ltd Protein
US8337382B2 (en) 2007-11-01 2012-12-25 John R. Adler, Jr. Radiosurgical neuromodulation devices, systems, and methods for treatment of behavioral disorders by external application of ionizing radiation
WO2009063776A1 (en) 2007-11-02 2009-05-22 Humanix Co., Ltd. Method of capturing cell fluid and analyzing components thereof while observing cell and system for capturing and analyzing cell fluid
AU2008321225B2 (en) 2007-11-13 2013-08-01 Phoenix Biotechnology Inc. Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
DE102007047797B8 (en) 2007-11-15 2011-12-15 Leica Biosystems Nussloch Gmbh A method for applying a histological cut produced on a blade of a microtome to a slide
WO2009066285A2 (en) 2007-11-19 2009-05-28 Dekel Shlomi A dynamic method and system for representing a three dimensional object navigated from within
JP5002763B2 (en) 2007-11-21 2012-08-15 セイコーインスツル株式会社 Thin section manufacturing apparatus and thin section manufacturing method
US20090156428A1 (en) 2007-11-30 2009-06-18 Malcolm Alastair J Multi-mode microarray apparatus and method for concurrent and sequential biological assays
EP2227774B1 (en) 2007-12-04 2014-07-09 University College Dublin, National University of Ireland Dublin Method and system for image analysis
US20090143669A1 (en) 2007-12-04 2009-06-04 Harms Steven E Color mapped magnetic resonance imaging
USD591864S1 (en) 2007-12-10 2009-05-05 Dako Denmark A/S Housing for a biological sample processing apparatus
JPWO2009078386A1 (en) 2007-12-14 2011-04-28 中外製薬株式会社 New specimen preparation method with excellent tissue morphology and nucleic acid quality
DE102008000035B4 (en) 2008-01-10 2011-02-24 Leica Biosystems Nussloch Gmbh Device for separating histological sections made with a microtome
DE102008000036B4 (en) 2008-01-10 2010-09-30 Leica Biosystems Nussloch Gmbh Method for making histological sections and microtome with an applicator and cutter
US8257700B2 (en) 2008-02-05 2012-09-04 The Board Of Trustees Of The Leland Stanford Junior University Proteomic analysis of active multiple sclerosis lesions
DE102008000262B4 (en) 2008-02-08 2010-07-01 Leica Biosystems Nussloch Gmbh Apparatus and method for filtering microtome cut waste in airflow
EP2110076A1 (en) 2008-02-19 2009-10-21 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Method and device for near-field dual-wave modality imaging
WO2009106642A1 (en) 2008-02-29 2009-09-03 Coloplast A/S Biosynthetic cartilaginous matrix and methods for their production
WO2009106081A1 (en) 2008-02-29 2009-09-03 Dako Denmark A/S Systems and methods for tracking and providing workflow information
KR20110005812A (en) 2008-03-17 2011-01-19 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 How to detect liver cancer cells using anti-glycancan-3 antibody
KR101189550B1 (en) 2008-03-21 2012-10-11 아츠시 타카하시 Three-dimensional digital magnifier operation supporting system
US20090253163A1 (en) 2008-04-02 2009-10-08 General Electric Company Iterative staining of biological samples
CN101559243A (en) 2008-04-18 2009-10-21 中国科学院上海硅酸盐研究所 Preparation method of tubular electrospinning fibre material
US8064488B2 (en) 2008-05-15 2011-11-22 Lockheed Martin Corporation Mid-IR laser for generation of ultrasound
US7821646B2 (en) 2008-05-15 2010-10-26 Lockheed Martin Corporation Method and apparatus for generating mid-IR laser beam for ultrasound inspection
US8113056B2 (en) 2008-05-15 2012-02-14 Lockheed Martin Corporation Mid-IR laser for generation of ultrasound using a CO2 laser and harmonic generation
US8054470B2 (en) 2008-05-15 2011-11-08 Lockheed Martin Corporation Method and apparatus for spectroscopic characterization of samples using a laser-ultrasound system
JP5366612B2 (en) 2008-05-20 2013-12-11 株式会社東芝 Image processing apparatus, image processing method, and image processing program
US8287938B1 (en) 2008-05-20 2012-10-16 Ingo Scheer Method to produce a coating and to fine-tune the coating morphology
EP2288729A1 (en) 2008-05-20 2011-03-02 Dako Denmark A/S A combined method for predicting the response to an anti-cancer therapy
US8598543B2 (en) 2008-05-22 2013-12-03 Vladimir Balakin Multi-axis/multi-field charged particle cancer therapy method and apparatus
US8565507B2 (en) 2008-05-23 2013-10-22 University Of Rochester Automated placental measurement
US20090292198A1 (en) 2008-05-23 2009-11-26 Svein Kleiven Non-invasive brain injury evaluation
EP2130491B1 (en) 2008-06-06 2015-08-05 Cefla S.C. Method and apparatus for radiographic imaging
US20090325223A1 (en) 2008-06-24 2009-12-31 Timothy Boyd Magnetic immunohistochemical staining device and methods of use
EP2310414B1 (en) 2008-06-30 2016-06-22 Dako Denmark A/S Pax 5 monoclonal antibody
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
US9097702B2 (en) 2008-07-29 2015-08-04 Cornell University Pathologically relevant tumor microenvironments for high-throughput drug screening
EP2349107B1 (en) 2008-08-14 2016-12-21 Oxford Performance Materials, Inc. Customized implants for bone replacement
DK2316010T3 (en) 2008-08-27 2022-03-28 The Univ Of Miami Tissue cassette and method of making tissue samples
WO2010024485A1 (en) 2008-08-29 2010-03-04 Korea Advanced Institute Of Science And Technology Apparatus and method for multiple immunoassays on a chip
US8515201B1 (en) 2008-09-18 2013-08-20 Stc.Unm System and methods of amplitude-modulation frequency-modulation (AM-FM) demodulation for image and video processing
US20100081916A1 (en) 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Histological facilitation systems and methods
US20100162416A1 (en) 2008-09-29 2010-06-24 Stemlifeline, Inc. Multi-stage stem cell carcinogenesis
US20100081190A1 (en) 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081919A1 (en) 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081915A1 (en) 2008-09-29 2010-04-01 Searete Llc, Alimited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081924A1 (en) 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
WO2010037395A2 (en) 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US8420884B2 (en) 2008-10-16 2013-04-16 Tufts Medical Center Inc. Models of malignant brain cancer, and therapeutic siRNAs against oncogenic signaling pathways, and methods and kits for uses therefor
TW201016844A (en) 2008-10-17 2010-05-01 Yeong-Shin Tarng Automatic punch and packing equipment for tissue array
US8077386B2 (en) 2008-10-22 2011-12-13 Microbrightfield, Inc. Movable objective lens assembly for an optical microscope and optical microscopes having such an assembly
EP2340433B1 (en) 2008-10-23 2018-04-18 Koninklijke Philips N.V. Colour management for biological samples
US8386015B2 (en) 2008-10-27 2013-02-26 Siemens Aktiengesellschaft Integration of micro and macro information for biomedical imaging
US8603496B2 (en) 2008-10-31 2013-12-10 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US20110238322A1 (en) 2008-11-03 2011-09-29 Precision Therapeutics, Inc. Methods of simulating chemotherapy for a patient
US20100121172A1 (en) 2008-11-12 2010-05-13 Siemens Corporate Research, Inc. Microscopic and macroscopic data fusion for biomedical imaging
US11059872B2 (en) 2008-11-14 2021-07-13 Bondwell Technologies Lp Self-assembly of protein-based biomaterials with multiple morphologies
IT1391829B1 (en) 2008-11-21 2012-01-27 C N R Consiglio Naz Delle Ricerche EQUIPMENT BASED ON ULTRASOUNDS TO MEASURE PARAMETERS ADVANCEMENT INDICATORS OF A PARTY
US8687856B2 (en) 2008-11-26 2014-04-01 Bioptigen, Inc. Methods, systems and computer program products for biometric identification by tissue imaging using optical coherence tomography (OCT)
US8787623B2 (en) 2008-11-26 2014-07-22 Bioptigen, Inc. Methods, systems and computer program products for diagnosing conditions using unique codes generated from a multidimensional image of a sample
CA2745431A1 (en) 2008-12-03 2010-06-10 Timothy J. O'leary Pressure-assisted molecular recovery (pamr) of biomolecules, pressure-assisted antigen retrieval (paar), and pressure-assisted tissue histology (path)
MX2011006287A (en) 2008-12-15 2011-06-27 Advanced Medical Diagnostics Holding S A Method and device for planning and performing a biopsy.
ES2343721B1 (en) 2008-12-19 2011-06-06 Histocell, S.L. CELL TRANSPORTATION SYSTEM.
WO2010075385A2 (en) 2008-12-23 2010-07-01 Tufts University Methods and system for confocal light scattering spectroscopic imaging
US20130210648A1 (en) 2009-01-14 2013-08-15 The United States of America, as Represented by the Secretary, Department of Health and Human Services Ratio based biomarkers and methods of use thereof
US20100204973A1 (en) 2009-01-15 2010-08-12 Nodality, Inc., A Delaware Corporation Methods For Diagnosis, Prognosis And Treatment
DK2389116T3 (en) 2009-01-22 2018-02-12 Biopath Automation Llc BIOPSY SUPPORT TO ORIENT TESTS FOR SECTION IN A MICROTOM
KR101822662B1 (en) 2009-02-04 2018-01-26 예일 유니버시티 Tissue engineering of lung
US20100203553A1 (en) 2009-02-11 2010-08-12 Abdeen Suad M Histochemical and biomarker for liver fibrosis
CN101477241B (en) 2009-02-19 2012-10-31 华中科技大学 Micro-optical scanning tomography device
CN102325895B (en) 2009-02-19 2015-09-23 丹麦达科有限公司 conjugate molecules
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
US8753824B2 (en) 2009-04-03 2014-06-17 University Of Virginia Patent Foundation Serial multiple antigen colocalization in paraffin-embedded tissue
JP5337870B2 (en) 2009-04-10 2013-11-06 独立行政法人国立循環器病研究センター Head model for brain imaging device and its manufacturing technology
EP3299812B1 (en) 2009-04-13 2020-03-11 University of Washington Rare particle detection method and apparatus
US20110261367A1 (en) 2009-04-27 2011-10-27 Gmitro Arthur F Integrated Confocal and Spectral-Domain Optical Coherence Tomography Microscope
BRPI1007627A2 (en) 2009-04-28 2018-03-06 Koninklijke Philips Electrnics N. V. method for use in biology, histology and pathology, equipment or system for use in biology, histology and pathology data support and information processing systems for use in biology histology and pathology
WO2010129494A2 (en) 2009-05-04 2010-11-11 Oregon Health & Science University Method and apparatus for quantitative imaging of blood perfusion in living tissue
US8517955B2 (en) 2009-05-08 2013-08-27 Broncus Medical Inc. Tissue sampling devices, systems and methods
WO2010138610A2 (en) 2009-05-26 2010-12-02 The Johns Hopkins University Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
US8063385B2 (en) 2009-05-29 2011-11-22 General Electric Company Method and apparatus for ultraviolet scan planning
EP2456358A1 (en) 2009-07-24 2012-05-30 Galderma Research & Development Infrared imaging of cutaneous melanoma
US8948488B2 (en) 2009-07-31 2015-02-03 General Electric Company Methods and systems for digitally enhancing an image of a stained material
RU2012110181A (en) 2009-08-17 2013-09-27 Орган Текнолоджиз Инк. METHOD FOR OBTAINING AN ARTIFICIAL BODY
US8463741B2 (en) 2009-09-04 2013-06-11 Omnyx, LLC Digital pathology system
WO2011030812A1 (en) 2009-09-10 2011-03-17 株式会社 日立メディコ Ultrasonic diagnostic device and elasticity image display method
US8691974B2 (en) 2009-09-28 2014-04-08 Virginia Tech Intellectual Properties, Inc. Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering
US20110075914A1 (en) 2009-09-30 2011-03-31 General Electric Company System and method for the quantitative assessment of digital histology images
US20110081056A1 (en) 2009-10-05 2011-04-07 Salafia Carolyn M Automated placental measurement
JP5540102B2 (en) 2009-10-12 2014-07-02 ベンタナ メディカル システムズ, インコーポレイテッド Multiple modality contrast and bright field context representation for enhanced pathological determination, and multiple specimen detection in tissues
WO2011046511A1 (en) 2009-10-13 2011-04-21 Agency For Science, Technology And Research A method and system for segmenting a liver object in an image
EP2312534A3 (en) 2009-10-15 2011-07-06 Hitachi Aloka Medical, Ltd. Ultrasonic volume data processing device
US20140038291A1 (en) 2009-10-31 2014-02-06 New World Laboratories Inc. Methods for reprogramming cells and uses thereof
AU2010312240B2 (en) 2009-10-31 2016-12-15 Genesis Technologies Limited Methods for reprogramming cells and uses thereof
US9453205B2 (en) 2009-10-31 2016-09-27 Genesis Technologies Limited Methods for reprogramming cells and uses thereof
JP5689073B2 (en) 2009-11-18 2015-03-25 株式会社日立メディコ Ultrasonic diagnostic apparatus and three-dimensional elastic ratio calculation method
US20110125016A1 (en) 2009-11-25 2011-05-26 Siemens Medical Solutions Usa, Inc. Fetal rendering in medical diagnostic ultrasound
HUP0900741A2 (en) 2009-11-27 2011-07-28 3Dhistech Kft Assembly and procedure for digitization of moving slide
RU2576033C2 (en) 2009-12-03 2016-02-27 Опко Хелс, Инк. Hypersulphated disaccharide based formulations
US9445780B2 (en) 2009-12-04 2016-09-20 University Of Virginia Patent Foundation Tracked ultrasound vessel imaging
US20110177590A1 (en) 2009-12-11 2011-07-21 Drexel University Bioprinted Nanoparticles and Methods of Use
US8582858B2 (en) 2009-12-17 2013-11-12 The Regents Of The University Of California Method and apparatus for quantitative analysis of breast density morphology based on MRI
WO2011075676A2 (en) 2009-12-18 2011-06-23 Knowlton Edward W A skin treatment and drug delivery device
US9058665B2 (en) 2009-12-30 2015-06-16 General Electric Company Systems and methods for identifying bone marrow in medical images
WO2011085002A1 (en) 2010-01-05 2011-07-14 University Of Cincinnati Serum spla2-iia as diagnosis marker for prostate and lung cancer
US20110166455A1 (en) 2010-01-07 2011-07-07 Cully Edward H Catheter
CN102883659A (en) 2010-01-19 2013-01-16 美敦力阿迪安卢森堡有限公司 Methods and apparatus for renal neuromodulation via stereotactic radiotherapy
US8178358B2 (en) 2010-01-28 2012-05-15 National Defense Medical Center Serpine2 as a biomarker for IgA nephropathy
WO2011093108A1 (en) 2010-02-01 2011-08-04 パナソニック株式会社 Ultrasonic probe and ultrasonic examination device using same
WO2011100691A1 (en) 2010-02-12 2011-08-18 Delphinus Medical Technologies, Inc. Method of characterizing the pathological response of tissue to a treatmant plan
CN102869301B (en) 2010-02-12 2016-06-29 戴尔菲纳斯医疗科技公司 The method characterizing the tissue of patient
WO2011103330A2 (en) 2010-02-17 2011-08-25 The Johns Hopkins University Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
US9566047B2 (en) 2010-02-25 2017-02-14 Erez Nevo Cryogenic biopsy system and method
US8609354B2 (en) 2010-03-04 2013-12-17 Olli CARPEN Method for selecting patients for treatment with an EGFR inhibitor
US9339194B2 (en) 2010-03-08 2016-05-17 Cernoval, Inc. System, method and article for normalization and enhancement of tissue images
US20120108452A1 (en) 2010-03-09 2012-05-03 Life Technologies Corporation Semi-Invasive Method for Characterizing Lung Injury
US8532398B2 (en) 2010-03-26 2013-09-10 General Electric Company Methods and apparatus for optical segmentation of biological samples
AR081747A1 (en) 2010-03-31 2012-10-17 Opko Health Inc PHARMACEUTICAL COMPOSITION OF HYPERSULPHATED GLUCOPIRANOSIDS
US8396269B2 (en) 2010-04-08 2013-03-12 Digital Pathco LLC Image quality assessment including comparison of overlapped margins
US10441428B2 (en) 2010-05-03 2019-10-15 New York University Early intervention knee implant device and methods
US8352060B2 (en) 2010-05-05 2013-01-08 Hankookin, LLC. Computer-aided fabrication of a removable dental prosthesis
WO2011143121A2 (en) 2010-05-10 2011-11-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Spatial-domain low-coherence quantitative phase microscopy
DE102010021534A1 (en) 2010-05-19 2011-11-24 Eberhard-Karls-Universität Tübingen Universitätsklinikum Direct investigation of biological material ex vivo
US20110286654A1 (en) 2010-05-21 2011-11-24 Siemens Medical Solutions Usa, Inc. Segmentation of Biological Image Data
US8823954B2 (en) 2010-05-24 2014-09-02 Fairfield University Low coherence enhanced backscattering tomography and techniques
FR2962573B1 (en) 2010-06-16 2019-04-12 Imascap METHOD FOR AUTOMATICALLY IDENTIFYING THE CONTOURS OF A PREDEFINED OS, DERIVED METHODS, AND CORRESPONDING COMPUTER PROGRAM PRODUCTS
EP2402370A1 (en) 2010-06-29 2012-01-04 Pierre Fabre Médicament Novel antibody for the diagnosis and/or prognosis of cancer
JP5658931B2 (en) 2010-07-05 2015-01-28 オリンパス株式会社 Image processing apparatus, image processing method, and image processing program
CA2806062A1 (en) 2010-07-19 2012-01-26 Arcion Therapeutics, Inc. Topical treatment of neuropathic pain and methods of diagnosis
EP2601528B1 (en) 2010-08-02 2015-10-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel methods for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor
US20130183710A1 (en) 2010-08-17 2013-07-18 Siemens Healthcare Diagnostics Inc. Reference sample for quality control in molecular diagnosis
US8508589B2 (en) 2010-08-30 2013-08-13 General Electric Company Imaging systems and associated methods thereof
WO2012028896A1 (en) 2010-08-31 2012-03-08 B-K Medical Aps 3d view of 2d ultrasound images
US20120058509A1 (en) 2010-09-08 2012-03-08 Eric Jeffords Leininger Apparatus and method for affixing frozen tissue sections to glass or membrane microscope slides
FR2964744B1 (en) 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines PROGNOSTIC TEST OF THE EVOLUTION OF A SOLID TUMOR BY ANALYSIS OF IMAGES
EP2616903B1 (en) 2010-09-16 2016-07-27 Omnyx LLC Control configuration for digital image system
WO2012037419A2 (en) 2010-09-16 2012-03-22 Omnyx, LLC Digital pathology image manipulation
WO2012037416A1 (en) 2010-09-16 2012-03-22 Omnyx, LLC Histology workflow management system
DE102010046498B3 (en) 2010-09-24 2011-12-15 Hans Heid Rotary microtome for cutting thin sample in laboratory, has adjustable weight comprising guide connected with drive shaft, and control element controlling operation of adjustable units by balancing center of gravity of drive axle
PT2619576T (en) 2010-09-24 2020-09-14 Niels Grabe MEANS AND METHODS FOR FORECASTING RESPONSE TO THE TREATMENT OF A PATIENT WITH CANCER
US8620045B2 (en) 2010-10-15 2013-12-31 Bruce William Adams System , method and article for measuring and reporting craniomandibular biomechanical functions
HUE029316T2 (en) 2010-11-04 2017-03-28 Univ Of Pecs Tüdõszövetmodell
WO2012061940A1 (en) 2010-11-08 2012-05-18 Colibri Technologies Inc. Systems and methods for improved visualization during minimally invasive procedures
US10180426B2 (en) 2010-11-08 2019-01-15 Dako Denmark A/S Quantification of single target molecules in histological samples
EP2641079A2 (en) 2010-11-15 2013-09-25 Tissuevision, Inc. Systems and methods for imaging and processing tissue
US20120122087A1 (en) 2010-11-17 2012-05-17 Weiwei Li 5-Hydroxymethylcytosine as a biomarker for early detection, treatment and prognostic monitoring of cancer
US9280718B2 (en) 2010-11-24 2016-03-08 Nocimed, Llc Systems and methods for automated voxelation of regions of interest for magnetic resonance spectroscopy
US9208556B2 (en) 2010-11-26 2015-12-08 Quantitative Insights, Inc. Method, system, software and medium for advanced intelligent image analysis and display of medical images and information
US8818069B2 (en) 2010-11-30 2014-08-26 General Electric Company Methods for scaling images to differing exposure times
US8673643B2 (en) 2010-11-30 2014-03-18 General Electric Company Closed loop monitoring of automated molecular pathology system
CA2817161C (en) 2010-12-06 2019-04-02 Dako Denmark A/S Combined histological stain
US8711149B2 (en) 2010-12-08 2014-04-29 Definiens Ag Graphical user interface for interpreting the results of image analysis
WO2012087962A2 (en) 2010-12-20 2012-06-28 Genentech, Inc. Anti-mesothelin antibodies and immunoconjugates
RU2013133415A (en) 2010-12-21 2015-01-27 Простексис Пти Лтд MENISK PROSTHESES AND THE METHOD OF THEIR IMPLANTATION IN HUMAN KNEE JOINT
WO2012088299A2 (en) 2010-12-21 2012-06-28 Savsu Technologies Llc Insulated storage and transportation containers
WO2012088311A2 (en) 2010-12-21 2012-06-28 Savsu Technologies Llc Insulated storage system with balanced thermal energy flow
US8530228B2 (en) 2010-12-28 2013-09-10 Bexmart Integrated versatile and systems preparation of specimens
US8388891B2 (en) * 2010-12-28 2013-03-05 Sakura Finetek U.S.A., Inc. Automated system and method of processing biological specimens
US9063074B2 (en) 2010-12-30 2015-06-23 Empire Technology Development Llc Analyzing tissue morphology in three dimensions
US20120220866A1 (en) 2010-12-31 2012-08-30 Volcano Corporation Deep Vein Thrombosis Therapeutic Methods Using Therapeutic Inflatable Devices and Systems
US8709359B2 (en) 2011-01-05 2014-04-29 Covaris, Inc. Sample holder and method for treating sample material
US20120191020A1 (en) 2011-01-25 2012-07-26 Shuki Vitek Uniform thermal treatment of tissue interfaces
US9200258B2 (en) 2011-01-27 2015-12-01 University Of Maryland, Baltimore Multicellular organotypic model of human intestinal mucosa
CN102625022B (en) 2011-01-29 2014-05-28 麦克奥迪实业集团有限公司 Rapid microscopic section scanning method with image space compensation motion and apparatus thereof
US9297995B2 (en) 2011-02-11 2016-03-29 University Of South Florida Automatic stereological analysis of biological tissue including section thickness determination
US9392986B2 (en) 2011-02-14 2016-07-19 University Of Rochester Method and apparatus for cone beam breast CT image-based computer-aided detection and diagnosis
KR101223937B1 (en) 2011-02-22 2013-01-21 주식회사 모르페우스 Face Image Correcting Simulation Method And System Using The Same
WO2012117294A2 (en) 2011-02-28 2012-09-07 Dako Denmark A/S Two phase immiscible system for the pretreatment of embedded biological samples
US8476585B2 (en) 2011-03-02 2013-07-02 Gatan, Inc. Microtome utilizing a movable knife in a retardation field scanning electron microscope and a retardation field scanning electron microscope including the same
JP2014515821A (en) 2011-03-27 2014-07-03 オンコステム ダイアグノスティックス(モーリシャス)プライベート リミテッド Markers, methods and kits for identifying tumor cells
US8718350B2 (en) 2011-04-08 2014-05-06 Regents Of The University Of Minnesota Computerized methods for tissue analysis
EP2693951B1 (en) 2011-04-08 2018-10-24 Algotec Systems Ltd. Image analysis for specific objects
US8852592B2 (en) 2011-05-10 2014-10-07 Biocare Medical, Llc Systems and methods for anti-PAX8 antibodies
WO2012156402A1 (en) 2011-05-16 2012-11-22 Universite Libre De Bruxelles Device for visualization and three-dimensional reconstruction in endoscopy
US9546979B2 (en) 2011-05-18 2017-01-17 Purdue Research Foundation Analyzing a metabolite level in a tissue sample using DESI
WO2012171996A1 (en) 2011-06-15 2012-12-20 F. Hoffmann-La Roche Ag Anti-human epo receptor antibodies and methods of use
DE102011051097B4 (en) 2011-06-16 2013-08-08 Leica Biosystems Nussloch Gmbh Microtome for cutting histological samples with helical capillary tube
US8699769B2 (en) 2011-07-12 2014-04-15 Definiens Ag Generating artificial hyperspectral images using correlated analysis of co-registered images
US8967024B2 (en) 2011-07-20 2015-03-03 Vertex Pharmaceuticals, Inc. Device to collect and segregate tissue samples sectioned on a microtome
US20130058871A1 (en) 2011-07-28 2013-03-07 Howard Hughes Medical Institute Method and system for mapping synaptic connectivity using light microscopy
CA2842282C (en) * 2011-07-28 2019-09-24 Medetect Ab Method for providing images of a tissue section
CN102423264B (en) * 2011-09-01 2014-05-21 中国科学院深圳先进技术研究院 Method and device for measuring elasticity of biological tissue based on image
US10096033B2 (en) 2011-09-15 2018-10-09 Stephan HEATH System and method for providing educational related social/geo/promo link promotional data sets for end user display of interactive ad links, promotions and sale of products, goods, and/or services integrated with 3D spatial geomapping, company and local information for selected worldwide locations and social networking
US20130289381A1 (en) 2011-11-02 2013-10-31 Seno Medical Instruments, Inc. Dual modality imaging system for coregistered functional and anatomical mapping
WO2013079072A1 (en) 2011-11-30 2013-06-06 Dako Denmark A/S Method and system for automated deparaffinization and non-immunohistochemical special staining of tissue samples
US10255410B2 (en) 2011-12-01 2019-04-09 Interpace Diagnostics Corporation Methods for treating Barrett's metaplasia and esophageal adenocarcinoma
US10131942B2 (en) 2011-12-01 2018-11-20 Interpace Diagnostics Corporation Methods for treating barrett's metaplasia and esophageal adenocarcinoma
US9032854B2 (en) * 2011-12-21 2015-05-19 Sakura Finetek U.S.A., Inc. Reciprocating microtome drive system
US8693000B2 (en) 2011-12-22 2014-04-08 General Electric Company Quantitative phase microscopy for label-free high-contrast cell imaging
CN102590155A (en) 2012-01-16 2012-07-18 华中科技大学 Tissue slice scanning and imaging device
ITTO20120030A1 (en) 2012-01-17 2013-07-18 Consiglio Nazionale Ricerche PROCEDURE AND SYSTEM FOR THE DETERMINATION OF THE VOLUME OF EPICARDIC CARDIAC FAT FROM VOLUMETRIC IMAGES, AND ITS PROGRAM FOR PROCESSOR
US20140031677A1 (en) 2012-01-20 2014-01-30 Physical Sciences, Inc. Apparatus and Method for Aiding Needle Biopsies
JP6148257B2 (en) 2012-01-23 2017-06-14 トモウェーブ ラボラトリーズ,インク. Laser photoacoustic ultrasonic imaging system (Louis) and method of use
US20130190594A1 (en) 2012-01-23 2013-07-25 Alexander A. Oraevsky Scanning Optoacoustic Imaging System with High Resolution and Improved Signal Collection Efficiency
US20130218978A1 (en) 2012-02-17 2013-08-22 Numira Biosciences Systems and Methods for Project Collaboration in a Cloud Computing Environment
US9506907B2 (en) 2012-02-20 2016-11-29 The Research Foundation Of State University Of New York Bioengineered human trabecular meshwork for biological applications
ES2878548T3 (en) 2012-02-26 2021-11-19 Caliber Imaging & Diagnostics Inc Tissue specimen stage for an optical sectioning microscope
AU2013230025A1 (en) 2012-03-06 2014-09-25 Southern Research Institute Three-dimesional, prevascularized, engineered tissue constructs, methods of making and methods of using the tissue constructs
WO2013142478A1 (en) 2012-03-19 2013-09-26 Savsu Technologies Llc System and method for transport of temperature sensitive materials
US20130252240A1 (en) 2012-03-21 2013-09-26 Ventana Medical Systems, Inc. Cryoembedded cell concentrates, methods for making, and methods for using
US20130345559A1 (en) 2012-03-28 2013-12-26 Musc Foundation For Reseach Development Quantitative perfusion analysis for embolotherapy
US8900529B2 (en) 2012-04-27 2014-12-02 General Electric Company Microfluidic chamber device and fabrication
US9031306B2 (en) 2012-05-02 2015-05-12 The Regents Of The University Of California Diagnostic and prognostic histopathology system using morphometric indices
WO2013174862A1 (en) 2012-05-24 2013-11-28 Leica Microsystems Cms Gmbh Specimen collector for collecting a laser micro-dissectate
EP2856165A4 (en) 2012-05-25 2016-05-11 Metavi Labs Inc Automated detection, tracking and analysis of cell migration in a 3-d matrix system
TW201348703A (en) 2012-05-30 2013-12-01 Univ Nat Taiwan Hospital Method for analyzing apoptosis inducing factor-2
US8964183B2 (en) 2012-05-31 2015-02-24 General Electric Company Systems and methods for screening of biological samples
US9097900B2 (en) 2012-06-14 2015-08-04 General Electric Company Quantitative phase microscopy for high-contrast cell imaging using frequency domain phase shift
US9164015B2 (en) 2012-06-29 2015-10-20 General Electric Company Systems and methods for processing and imaging of biological samples
US20140024024A1 (en) 2012-07-17 2014-01-23 General Electric Company Methods of detecting dna, rna and protein in biological samples
US9277970B2 (en) 2012-07-19 2016-03-08 Siemens Aktiengesellschaft System and method for patient specific planning and guidance of ablative procedures for cardiac arrhythmias
US9194775B2 (en) 2012-07-30 2015-11-24 Aspect Imaging Ltd. Guided slicing system for obtaining histological samples and methods thereof
US9334473B2 (en) 2012-08-17 2016-05-10 Jelena Vukasinovic Three dimensional cell culture compositions and methods of use
US20140055853A1 (en) 2012-08-27 2014-02-27 General Electric Company Open top microfluidic device for multiplexing
US20140094806A1 (en) 2012-10-02 2014-04-03 Lanny Leo Johnson Surgical instrument for penetrating removing bone
DE102012219684B4 (en) 2012-10-26 2017-05-11 Leica Biosystems Nussloch Gmbh Portable device for transporting a histological sample
US8599388B1 (en) 2012-11-02 2013-12-03 The Board Of Trustees Of The University Of Illinois Coherent optical mapping of particles
KR20160083014A (en) * 2013-10-31 2016-07-11 3스캔 인크. Motion strategies for scanning microscope imaging
CN204065544U (en) 2014-07-29 2014-12-31 杭州卓腾信息技术有限公司 Based on microscopical digital slices autoscan three-dimensional motion device
EP3076150A1 (en) 2015-03-30 2016-10-05 3Scan Inc. Methods and apparatuses for sectioning and imaging samples

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050062897A1 (en) * 2003-08-01 2005-03-24 Zhichun Lei Method for pre-processing image data
US20140228707A1 (en) * 2013-02-11 2014-08-14 Definiens Ag Coregistering Images of Needle Biopsies Using Multiple Weighted Landmarks
US20150287194A1 (en) * 2013-02-11 2015-10-08 Definiens Ag Updating Landmarks to Improve Coregistration as Regions of Interest are Corrected
US9177378B2 (en) * 2013-02-11 2015-11-03 Definiens Ag Updating landmarks to improve coregistration as regions of interest are corrected

Also Published As

Publication number Publication date
US20170011511A1 (en) 2017-01-12
KR20170007181A (en) 2017-01-18
JP2017021028A (en) 2017-01-26
EP3115766A1 (en) 2017-01-11
JP6841609B2 (en) 2021-03-10
US10839509B2 (en) 2020-11-17
CN106338423A (en) 2017-01-18
TW201709150A (en) 2017-03-01
CN106338423B (en) 2020-07-14

Similar Documents

Publication Publication Date Title
US20210073980A1 (en) Spatial multiplexing of histological stains
US8995733B2 (en) Microdissection method and information processing system
US20240159629A1 (en) Systems and methods for meso-dissection
US11079307B2 (en) System and method for anatomical pathology sample handling, storage, and analysis
EP3323107B1 (en) Information transformation in digital pathology
US20080032328A1 (en) System and method for co-registering multi-channel images of a tissue micro array
US20170322124A1 (en) Systems and methods for meso-dissection
RU2707326C2 (en) Tissue microarray analysis
JP7601325B2 (en) Sample analysis method and image processing method
CN107624159A (en) For checking and handling the method and inspection system of micro- sample
US20090304244A1 (en) Method and a system for presenting sections of a histological specimen
JP2008188012A (en) Molecular histology
Lawson et al. Immunofluorescence-guided segmentation of three-dimensional features in micro-computed tomography datasets of human lung tissue
JP7650742B2 (en) Specimen image registration method, specimen image analysis method, program, and recording medium
Le Page et al. Tissue microarrays in studying gynecological cancers
Micheva et al. Array tomography: Imaging stained arrays
Zhuang et al. Evolutionary Paradigms in Histopathology Serial Sections technology
JP2021076581A (en) Facility and method for verifying source and/or quality of biological sample piece
JP2019138697A (en) Tissue section reconstruction correction method
Konishi et al. Semi-automated navigation for efficient targeting of electron tomography to regions of interest in volume correlative light and electron microscopy
US20080248478A1 (en) Molecular histological analysis of multicellular samples
Cruz et al. Three‐Dimensional Reconstruction of Tissues

Legal Events

Date Code Title Description
AS Assignment

Owner name: 3SCAN INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GOODMAN, MATTHEW;HUFFMAN, TODD;DANIEL, CODY;REEL/FRAME:054434/0333

Effective date: 20160802

STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION